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Metal organic frameworks (MOFs) are extended structures composed of a network of organic ligands and metal ions or clusters connected to each other via 
coordination bonds. The numerous choices of organic ligands and metal coordination geometries have led to the construction of porous MOFs with various 
compositions, network topologies, pore sizes and shapes and they possess high surface areas and low densities. The structures of MOFs can be tailor-tuned in 
such a way that any desired ligand or/and metal ion can be incorporated; this has given to researchers the advantage of designing MOFs for a targeted 
application. Within this review, we overview recent examples of a sub-class of MOFs namely biologically derived MOFs (bio-MOFs), made of multifunctional 
and commercially available biologically derived ligands  (bio-ligands) such as: amino acids, peptides, nucleobases and saccharides and focus on their 
coordination chemistry with a variety of metals. Central to this review are four tables detailing the coordination modes of bio-ligands to metals, along with a 
visual representation of the bio-MOF that is subsequently formed. Through the detail analysis of these structures, we highlight the structural impact of these 
ligands on the structure, and their contribution to the MOFs properties and applications. Finally, we showcase the potential of bio-MOFs in several research 
areas such as CO2 capture, separation, catalysis, drug delivery and sensing.
1. Introduction  
Metal organic frameworks (MOFs) are crystalline coordination 
based materials consisting of an infinite network of metal-ions, or 
metal-ion clusters, bridged by organic ligands through coordination 
bonds into porous two- or three- dimensional extended 
structures.[1, 2] The judicious selection of the metal ion and ligand 
has led to the discovery of a broad array of highly porous MOF 
materials with various topologies, compositions and properties such 
as record-breaking internal surface areas (up to 7000 m2/g),[3] high 
void volumes (up to 90%),[4] and low densities (as low as 0.126 
g/cm3).[5] The ability to chemically modify the pore surface of MOFs 
through pre- and post- synthetic introduction of functional groups, 
combined with the potential for the formation of open metal 
coordination sites, can also provide the means to tailor internal 
surfaces for applications related to gas separation and storage, 
catalysis, and sensing.[6] Compared with other frequently used 
ligands for MOF synthesis, biologically related ligands (such as amino 
acids, peptides, nucleobases and saccharides) offer the potential to 
utilize multiple coordination sites, and contain a variety of functional 
groups that can be advantageous in areas such as CO2 capture, 
separation and catalysis. They also, have added advantages such as 
controlling hydrogen-bonding interactions, resulting in structures 
that can be flexible or robust. Ultimately, bio-ligands allow 
researchers to buy any combination of chirality, aromaticity, cyclic or 
aliphatic features desired, or by buying the necessary backbone and 
synthetically altering it for further research investigations. This saves 
time, and can accelerate the rate of MOF discovery. With the vast 
amount of bio-ligands readily available, it is not surprising that these 
ligands have found their way into several applications, such as CO2 
capture/storage, enantioselective synthesis, etc. that other well-
known MOFs (e.g HKUST-1, MOF-74) have been known for.[7] To 
control the size and shape of a cavity in a particular MOF for a given 
application can still prove challenging to researchers, however the 
ligand design strategy (and their incorporation within the MOF 
structure) plays a significant role in the construction of functional 
MOFs. 
In this review, we highlight the importance of ligands in general 
and more specifically the impact of biologically related ligands 
(hereafter bio-ligands), in the design, structure and applications of 
biologically derived MOFs (hereafter bio-MOFs). More so, we will 
discuss the current work and challenges of incorporating bio-ligands 
into MOFs, and offer insights into this exciting sub-discipline of 
research.  
 
2. Ligand Design in MOFs 
Typically, the self-assembly of metal ions or clusters with ligands 
to form MOFs can be achieved through classical coordination 
chemistry methods (<100 oC),[1, 8] diffusion methods, solvothermal 
synthesis (>100 oC),[9] electrochemical methods, microwave 
synthesis,[10, 11] or high-throughput techniques. [12-14] While a 
variety of metal ions throughout the periodic table can be used, rigid 
organic ligands are generally preferred (over flexible) since the 
resulting MOFs can be robust and/or porous. [15-17] Commonly 
used organic ligands within MOFs are divided into families such as: i. 
carboxylic acid containing ligands, ii. nitrogen containing ligands 
(pyridyl, pyrryl, imidazolyl, etc), iii. cyano ligands, iv. phosphonic 
acids ligands, v. ligands based on mixed functional groups, vi. sulfonyl 
ligands and vii. metal-bearing ligands. [18, 19] While cationic ligands 
are less common in the synthesis of MOFs (low affinity to coordinate 
to metal cations), both neutral and charged ligands can be used. [8] 
Functionalities pointing towards their internal pore surface are often 
utilized to introduce strong interactions with a target molecule and 
can influence the framework structure. [18] In addition, they may 
have interconnecting functions, which could extend the coordination 
motifs, creating secondary interactions such as hydrogen bonding 
and aromatic stacking. [18], [20-23]  
With a wide variety of ligands available, many different strategies 
have been used to synthesize MOFs that target a specific application. 
Some of them can be summarized into six different categories:  
i. Using ligands that are identical in size but contain different 
functional groups can afford multivariate MOFs (MTV-MOFs). [22, 
23] This was demonstrated by Reimer et al., who combined Zn4O and 
BDC to form a MTV-MOF-5 family, which showed four-fold selectivity 
for CO2 over CO. [22] 
ii. Replacing the organic ligands in a MOF with units that are 
topologically similar or identical, but instead increasing in length, can 
extend the pore size, resulting in the construction of new families of 
isoreticular MOFs (IRMOFs) with unique properties. [24-29] This 
method can be used to increase the BET, CO2 capacity, and pore of 
the material. For example, in the IR-MOF-74-I to -IX series the pore 
apertures were increased for 14 to 98 Å, allowing for molecules such  
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as vitamin B12, or green fluorescent protein (GFP) to reside in their 
pores. [27] 
iii. Using ligands with specific functionalities to target 
applications such as CO2 capture and storage, or ligands that have 
specific functionalities to enhance their interaction with target 
molecules. For example, amine functionalized MOFs can be used to 
achieve a higher total adsorption energy of CO2 molecules. [28] 
iv. Increasing the conjugation of organic ligand can aid in the 
formation of MOFs with hydrophilic pores, or that can be used for 
light absorbing or sensing applications. [30-39] Ligands such as 
H4TCPB have been incorporated into MOFs, allowing for selective 
uptake of p-xylene over other isomers such as m-xylene. [35] While 
porphyrin based MOFs (Al-PMOF) have been used to harvest light for 
water reduction. [36] For Fluorescent MOFs, emission is dependent 
on the MOF structure, and effects such as metal-to-ligand charge 
transfer, ligand-to-ligand charge transfer and ligand-to-metal charge 
transfer have been reported.[40] Intra-ligand based luminescence is 
typically observed with organic ligands that are highly conjugated, 
susceptible to π-stacking in the solid state.[40], [41] 
     v. Fluorescent ligands can also be used in MOFs that are intended 
for biological applications, due to their ability to perform real-time 
measurements. [7], [42-49] For MOFs to be applicable for in vivo 
administration, the components of their framework should not 
intervene in the body’s cycle, and ideally be excreted from the body. 
[43] Some examples of exogenous MOFs found in biomedical 
applications are magnesium-2,5-dihydroxoterephthalate [CPO-27 
(Mg)],[50] FeIII polycarboxlyates [MIL-100-FeIII],[51] and zinc 
adeninate-4,4'-biphenyldicarboxylate (bio-MOF-1).[52] Organic 
ligands such as muconic acid, fumaric acid, trimesic acid, amino 
terephthalic acid and terephthalic acid have been used in the 
construction of non-toxic FeIII MOFs (MIL-89, -88A, -100, -100_NH2, 
and -53, respectively).[53] 
     vi. Chiral ligands can be used for the generation of homochiral 
porous MOFs, or chirality can be induced from the arrangement of 
achiral ligands within the structure. [54-57] Among the chiral ligands 
available, [58-64] bio-ligands, such as natural occurring peptides, are 
structurally rich and versatile with numerous metal binding sites. 
However, robust and highly porous MOFs based on these ligands are 
scarce in the literature. [56], [65-67]  
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3. Coordination Binding Modes of Bio-Ligands in 
MOFs  
We consider biologically derived MOFs (bio-MOFs), the MOFs 
which are constructed from biologically based ligands (bio-ligands). 
In this review, we will overview the coordination capabilities of four 
families of bio-ligands such as amino acids, peptides, nucleobases 
and saccharides within the MOF structures and their impact on the 
structural robustness/flexibility and physical properties of these 
materials. [7] Recently, there has been increasing interest in using 
bio-ligands as they offer several advantages such as commercial 
availability, simple synthetic routes for the development of new 
ligands, structural diversity, multiple different metal binding sites, 
and preinstalled chirality. [7] While the use of bio-ligands can lead to 
biologically compatible MOFs, some of them have added features 
such as self-assembly properties, which could be used to direct the 
structure and function of the bio-MOFs.[7] Over the last 5 years, bio-
MOFs have shown a great promise in several research fields such as 
CO2 capture, catalysis, sensing, and separation. This review is 
structured as follow: i. review of the coordination capabilities of bio-
ligands and their orientation around metal ions for the formation of 
extended frameworks and ii. research highlights on the potential 
applications of bio-MOFs.  
3.1. Amino Acids 
Amino acids are organic ligands containing both a carboxyl (-
COOH) and amino (-NH2) group that dominate their functional and 
physical properties. The organic side chain of amino acids can impart 
hydrophobic or hydrophilic character, with the presence of a polar 
  
 
(e.g alcohols) or non-polar (e.g alkyl chains) side chain, which is 
important for the formation of protein structures. Their rich 
coordination chemistry (through the carboxylate, amino groups and 
side chains) makes them as an attractive class of organic ligands for 
the formation of extended MOF structures. This however, has been 
limited due to the ease of formation of low-dimensional and compact 
frameworks. [7] To circumvent this challenge and form porous amino 
acid based MOFs, additional polydentate organic ligands and 
bridging anions, or chemically modified amino acids have be used to 
increase dimensionality in bio-MOFs made from natural occurring 
amino acids.[7]  
With both carboxylate and amino metal binding sites, amino 
acids tend to form discrete complexes through an O,N-chelating 
mode, forming a five-membered glycinate chelate ring. However, in 
some cases coordination of the α-carboxylate group to the metal 
ions can occur either through bi- or tri-dentate bridging modes 
creating extended frameworks.[7] One-dimensional coordination 
networks are commonly formed when pure amino acids are used  
however, [68] 2- and 3-dimensional MOFs can also be constructed. 
In the case of 2-dimensional metal-ion amino acids frameworks, a 
typical µ2-O1:O2 coordination mode can be obtained with glycine 
(Gly) and NiII (Table 1, entry 1), [69] MnII, [70] and CoII. [71] Two 
amino acid ligands can coordination through an O,N-chelation mode 
with a metal ion that allows octahedral coordination. However, by 
using the second oxygen atom of the amino acids carboxylate, 
bridging to a neighboring metal ions can occur through a µ2-N1O1:O2 
coordination mode. [7] This is found in bio-MOFs combining L-
phenylalanine (L-Phe) with MnII, [72] and CuII (Table 1, entry 2), [73] 
as well as L-glutamine (L-Gln) with CuII (Table 1, entry 3). [74]  
Three-dimensional bio-MOFs using pure amino acids are rare, 
however examples can be found when additional organic ligands or 
altered amino acids are used. Amino acids bearing side chains with 
metal binding groups can be used to bridge metal ions together. For 
example, Anokhina and Jacobson reported the first examples of a 
chiral 1-dimensional, optically pure product, with an extended helical 
subnetwork formulated as [Ni2O(L-Asp)(H2O)2]∙4H2O (where Asp is 
aspartic acid). [75] However, the increase of the pH to 7.2, leads in 
the formation of a 3-dimensional [Ni2.5(OH)(L-Asp)2]∙6.55H2O (Table 
1, entry 4) material that is based on comparable helices that are 
connected by additional [NiAsp2]-2 units to generate a porous chiral 
framework. [76] It was proposed that the formation of common 
helices in both complexes could be due to the strong tendency of the 
aspartate ligand to favor a tridentate chelation coordination mode, 
limiting the orientation and range of its bonds to additional metal 
centers. [76]   Following this, Zhang et al.  demonstrated the 
synthesis of two enantiomorphic MOFs with a SOD zeotype topology 
using enantiopure D- or L-alanine (D- or L-Ala). [77] The coordination 
environment of Ni(D-Ala)2 (Table 1, entry 5) demonstrated the 
presence of a 3-dimensional 4-connected SOD network in which the 
D-Ala anion chelates to the NiII metal center, acting as a µ2-bridging 
ligand. [77]  
Side chains that feature additional metal binding groups, such as 
methionine (Met) have also been used in the construction of 3-
dimensional bio-MOFs. Specifically, in the preparation of a 
homochiral heterobimetallic [Ag3Cu3(L-Met)∙6(NO3)3(H2O)]∙7H2O  
(Table 1, entry 6), where the L-Met ligands were found to bind to CuII 
ions (O,N-chelation mode) and AgI ions through the monodentate 
thioether group. [78] Metal-glutamate (Glu) complexes have also 
been recently investigated due to their model system simplicities, 
metal-protein interactions, and have been created into a series of 
nearly isostructural 3-dimensional bio-MOFs with metal ions such as 
CdII, [79, 80] ZnII, [81] CuII, [82, 83] and CoII (Table 1, entry 7).[84] 
Within [M(L- or D-Glu)(H2O)]∙ H2O, the Glu ligands are multidentate, 
coordinating to three different metal ion via µ2-N1O1:O2, µ1-O3:O4 and 
µ2-O3:O4 coordination modes. Other examples of amino acids bearing 
side chains with metal binding sites are the imidazole group of 
histidine (His) (Table 1, entry 8), [85] the thiol group of cysteine (Cys), 
as well as the phenol ring of tyrosine (Tyr). 
Increasing dimensionality can be achieved by using both amino 
acids and additional organic ligands or inorganic anion/clusters that 
act as linkers. [7] Recently, a non-chiral 3-dimensional bio-MOF, 
comprised of Gly and azide, was reported with the formula 
[Cu2(Gly)2(N3)]n, (Table 1, entry 9) that displayed an unusual 4-
connected 3-dimensional net with a Lonsdaleite (hexagonal 
diamond) topology and was the first example of a coordination 
polymer with a flexible amino acid as the secondary bridging ligand 
in metal-azido complex. [86] Another 3-dimensional non-chiral bio-
MOF was obtained using chiral L-Ala, Cu and Gd. It was the first 
heterometallic MOF containing both 3d CuII and 4f GdII metal ions, 
and contains both an amino acid and a bridging dicarboxylic ligand 
(1,3-benzene dicarboxylate) (Table 1, entry 10). [87]  
Isostructural 3-dimensional homochiral porous bio-MOFs [Co2(L-
Asp)2(4,4'-bipy)]∙1.5H2O (ferromagnetic) and [Co2(D-Asp)2(4,4'-
bipy)]n were constructed when the 2-dimensional CoII and L-Asp  
layers were interlinked with the linear bipy ligands.[88] In this case, 
each Asp dianion binds to three CoII ions through a tridentate 
coordination mode (amine and α and β-carboxylate groups) as well 
as through a monodentate fashion, in which the oxygen from the α- 
or β-carboxylate group links to a CoII ion.[88] Interestingly, bio-MOFs 
such as [Ni2(L-Asp)(bipy)] (Table 1, entry 11), can be extended 
through the substitution of the bipy pillars with ligands that have a 
similar connectivity, such as azpy, bpe, and 3rbp. [89] This includes 
ligands such as py3T and 35bpp which have a different topology and 
supplementary pyridyl group. [89] [Ni2(L-Asp)2(bipy)] displays a 
significant degree of enantioselectivity in the sorption of a family of 
small diols (e.e. up to 54%) due to the chirality of the pores, which is 
induced by the use of an enantiopure amino acid building block. The 
35bpp system, with channel dimensions ranging from 6.7 x 4.9 Å to 
10.3 x 5.4 Å, illustrates the possibility to introduce a basic active site 
within the pores. [89]  
In-situ dimerization of Asp (referred to as IDS), with bipy and Zn 
carbonate basic, lead to the formation of a mixed-ligand 3 
dimensional [Zn2(IDS)(bipy)] MOF (Table 1, entry 12). [90] The IDS 
ligand binds to 5 separate ZnII metal centers which are 
crystallographically present as two independent ZnII centers that are 
five (Zn2) and six (Zn1)-coordinated. Three coordination modes are 
present: i. an eight-membered ring through Zn1 is formed through 
two oxygen atoms and a nitrogen atom in an O-N-O tridentate mer 
chelation (two carboxylate groups and the amino group from the IDS 
ligand), ii. from the previous mode, the remaining oxygens bind two 
Zn2 metal centers, iii. finally, two crystallographically distinct ZnII 
metal centers are coordinated to the remaining carboxylate groups. 
[90] This work demonstrates the crucial role of the rigid organic 
ligands, and their ability to prevent filling of available spaces by 
flexible amino acid ligands, generating porosity in metal-amino acid 
extended frameworks. [90] 
In a similar system, the solvothermal reaction of 
ZnCO3·2ZnO·3H2O with Asp and bipy yielded a homochiral 3-
dimensional Zn-Asp-MOF with three distinct coordination 
geometries and coordination modes of Asp to ZnII (Table 1, entry 13). 
  
 
 
[91] Three distinct coordination modes of ZnII ions are 4-, 5-, and 6-
coordinated, with distortion away from their respective ideal 
geometries. [91] Within the motif, there are three 
crystallographically non-equivalent Asp ligands with three different 
coordination modes to Zn: i. one Asp ligand is bound to three 
different Zn metal centers with two types of coordination which are 
comprised of a commonly reported 5- and 6-membered N-O 
metallocycle, and where the remaining oxygens bridge to 
neighboring ions, ii. and iii. display three types of coordination modes 
and are bound to four ZnII ions. [91] These modes are: iv. through a 
five membered N-O metallocycle that is commonly found in metal-
amino acid chemistry, vi. via a pendant carboxylate group bridging to 
other ZnII ions, v. where the remaining oxygens form the bridge to 
other neighboring ions, similar to conformation i. [91]  This structure 
represents the first example of a chiral amino-acid derived 
compound with this structural framework. It should be noted that 
Asp has been reported in CuII frameworks with imidazole to form 
[Cu(L-Asp)(Im)]·2H2O.[92] The structure (Table 1 entry 14), is a 2-
dimensional framework with CuII atoms coordinated in a distorted 
square-pyramidal geometry via one Im molecule and three Asp ions. 
[92]   
Switching to the amino acid L-Tryptophan (L-Trp) with bpe and 
ZnII affords a MOF with formula of {[Zn2(L-
Trp)2(bpe)2(H2O)2]·2H2O·2NO3}n in which the Trp ligand acts as a 
bridging ligand and adopts a syn-anti mode by displaying both 
monodentate and chelate coordination modes, thereby forming 1-
dimensional chiral chains (Table 1 entry 15). [93] An extended 
neutral 2-dimensional coordination layer with homochiral rectangle-
like (4,4) topology is formed through the linking of adjacent chiral 
chains via a µ2-bpe bridges. [93] AAA packing is achieved via the 
stacking of [Zn2(L-Trp)2(bpe)2] layers, with the presence of significant 
hydrogen bonding interactions between the coordinated guest and 
water molecules. [93] Emission spectra confirmed that this MOF 
exhibited a green emission at 546 nm, and via dielectric studies 
revealed a low dielectric constant (κ = 2.53 at 1 MHz), confirming it’s 
candidacy for interlayer dielectrics. [93] After treatment with 
different solutions of anions, the results showed a change of κ value 
in experiments with the phosphate anion, it was also noted that 
secondary harmonic generation studies were double the intensity of 
SiO2. [93] 
Due to the intrinsic homochirality, multidentate coordination 
sites, and commercial availability, serine (Ser) is an attractive and 
functional bio-ligand for the formation of 3-dimensional, homochiral 
and isostructural nanoporous frameworks. [94]  Within this bio-MOF, 
[Zn4(bdc)2(L-Ser)2],  there are homochiral chains which are built from 
the Ser ligand and ZnII centers linked together by achiral bdc ligands 
affording a rod-and-spacer motif that has large rhombic channels 
(Table 1, entry 16). [94] The structure has notable coordination 
features such as the NH2 groups of L-Ser bridging two ZnII centers, 
with each five-coordinate Zn center having a trigonal bipyramid 
geometry, and an unusual µ4-Ser ligand (dianion) bound to four ZnII 
ions which is due to the deprotonation of the hydroxy group. [94] 
This bio-MOF exhibits high selectivity for CO2 over N2 and CO at 
ambient conditions (more in section 6). [94] 
The alteration of natural amino acid side chains allows for the 
potential to increase dimensionality of bio-MOFs. For example, the 
modification of the phenyl ring in Phe with a tetrazole affords a 3-
dimensional bio-MOF whereas 1- and 2-dimensional structures are 
common using a metal ion and non-modified Phe. [95] The two 
compounds, mono[(S)-5-(3-tetrazoyl)-phenylalaninato]zinc(II) and 
mono[(S)-5-(3-tetrazoyl)-phenylalaninato]cadmium(II) monoaqua 
reported by Li et al., were isostructural with a non-interpenetrated 
SrAl2 topology (Table 1, entry 17). [48] Rational design to adjust the 
"depth" and the "width" of the ligands showed that one could control 
the size and shape of the 2-dimensional ZnII and CdII chiral bio-MOFs 
by introducing different functionalities into the phenyl ring. [48] 
Moving out of the transition metals, isomorphous crystals with 
the composition of [Ln2(L-Glu)2(ClO4)4·9H2O] (Ln: DyIII or HoIII) have 
been reported by Huskowska et al. [96] In these structures, four 
carboxylate groups bridge two lanthanide ions in each complex, with 
two of the oxygens coordinated to both cations. [96] Bringing the 
coordination number to a total of nine, four water oxygens are found 
surrounding each cation; finally, the infinite layers are linked via L-
Glu acid ligands and the perchlorate groups located in the voids. [96] 
Other lanthanide based bio-MOFs have been reported; such as TbIII  
and EuIII  (DL-Cys and DL-Hval, L-Asp, and  DL-Val, respectively), [97] as 
well as SmIII, NdIII, and ErIII  (Gly, Ala, and Val, respectively). [98]   
3.2. Peptides 
Polymeric biomolecules that are composed of short chains of 
naturally occurring amino acids, and linked by a NHCO bond are 
peptides, and constitute the rational second step of complexity to 
evaluate the role of bio-ligands as bridging ligands in MOF structures. 
Each peptide has a distinct sequence depending on the 
conformation, and stereochemical configuration of their constituted 
amino acids. [99] Because of this, each peptide has specific 
recognition properties and intrinsic chirality that may be useful for a 
wide range of applications, including asymmetric catalysis and 
enantioselective separation. [99] More so, the majority of peptides 
are aliphatic which can give rise to MOFs with flexibility, and give 
researchers insight into how more complex molecules (proteins) fold 
or 'move'. [100] 
Similar to amino acids, peptides can coordinate through an O,N-
chelating mode, where the amino group coordinates to the metal 
ions either through chelation or a monodentate form, while the 
carbonyl oxygen coordinates to the same metal ion. Coordination of 
the carboxylate occurs through any of the well-known modes such as 
chelation, monodentate, syn-syn bridging, etc. Such features can be 
seen in even the simplest peptide, GlyGly. More importantly, the 
infinite versatility to design peptides by adding suitable amino acids 
to their sequence, can allow for the incorporation of more metal 
binding groups. For example, the incorporation of more carboxylate 
groups can be achieved by simply synthesizing peptides made from 
combining Asp and Glu. [7] This versatility opens the door to an 
unlimited number of flexible polydentate bio-ligands that could be 
used and form 1-, 2- and 3-dimensional robust or flexible bio-MOFs, 
which we will describe throughout this section.  
To date, most examples of bio-MOFs constructed from peptides 
only contain two amino acids. While some tripeptides are 
commercially available, they are more expensive and can be 
synthetically more demanding to make compared to dipeptides. The 
simplest and shortest peptide, GlyGly, has been used to construct 2-
dimensional bio-MOFs with formula of [M(GlyGly)2]∙2H2O (M: ZnII or 
CdII) (For Zn, Table 2, entry 1). [101] At pH 6, each GlyGly ligand, 
bridges two metal ions in a monodentate mode through the terminal 
carboxylate group and the amino group coordinates through a five 
membered chelation ring. Increasing the pH to 9 (and where M: CdII) 
the GlyGly ligands bind to two CdII ions through their terminal 
carboxylates, and the amino group to another CdII ion in a 
  
 
monodentate mode. [101] Changing the peptide to GlyGlu affords a 
structure with two ligands coordinated through the carboxylates 
(O10, O11, and O13, O14) with a coordination sphere that is described 
as a distorted square antiprism due to the coordination angles of the 
carboxylates (53.27o and 53.66o, respectively) (Table 2, entry 2). 
[102] Changing the metal to CoII affords a configuration where the 
CoII ions are positioned at the vertices of the Co-L-GlyGlu ladders 
(Table 2, entry 3). [65] The ladders are strongly connected via 
hydrogen bonds involving the amino group and carboxylate of GlyGlu 
in the neighboring ladders. [65] Along the c-axis, the ladders are also 
hydrogen bonded through a coordinated H2O molecules to the 
carboxylate group of an adjacent ladder. [65] 
Peptide derived bio-MOFs constructed from networks made 
from dipeptides such as [Zn(GlyThr)2]∙H2O,[103] [Cd(AlaThr)2]∙4H2O, 
[104] and [Zn(GlyAla)2]∙solvent [105] have been reported (Table 2, 
entries 4-6), and in the case of ZnII based bio-MOF [Zn(GlyThr)2], 
show good CO2/CH4 sorption selectivity. [106] The aforementioned 
2-dimensional metal-peptide layered structures are connected 
through strong hydrogen bonds and exhibit coordination modes to 
[M(GlyGly)2]∙2H2O (M: ZnII or CdII). [101] The stack of the 2-
dimensional layered structures of [Zn(GlyThr)2] and [Zn(GlyAla)2] 
results in the generation of 1-dimensional channels, however in the 
former bio-MOF, the presence of Thr leads in the formation of strong 
interactions with the adjacent layer, reinforcing the stability in the 3-
dimensional crystal structure. [106] For the latter [Zn(GlyAla)2], the 
pores collapse upon desolvation but they can be recovered when 
polar molecules diffuse into its pores. [105]  
GlyAsp based bio-MOFs can be prepared with either CoII or ZnII 
generating 3-dimensional frameworks with different topologies 
(Table 2, entry 7 and 8, respectively). [106] The structure of the CoII 
framework consists of dipeptides connecting four metal ions, and a 
unique seven membered ring formed through the coordination of a 
metal ion with alpha and beta carboxylate groups of the Asp residue 
in the dipeptide. [106] In this structure, the dimensionality arises 
from the side chains of Asp bridging two CoII ions. In the ZnII 
framework, the metal center is penta-coordinated, with each 
dipeptide connecting four Zn metal ions through a five-membered 
glycinate chelate ring. [106] While the coordination mode of CoII and 
orientation of GlyAsp  results in the formation of a 3-dimensional 
framework, the  ZnII based bio-MOF gives a 2-dimensional structure 
with layer parallel to the ab plane, and a rigid conformation of GlyAsp 
dipeptide with water molecules trapped in the intersheet plane. 
[106] 
  Changing the bio-ligand to GlySer, the reposition of the OH-
bearing Ser side chain allows for ordered cooperative, displacive, and 
conformational changes of the peptide (Table 2, entry 9). [107] This 
change from a methyl, to a primary alcohol, is a sufficient change in 
the framework to go from a solvated porous state (GlyAla) to a non-
porous state. The Zn(XY)2 (with XY representing the dipeptide of 
choice) dipeptide based bio-MOFs demonstrate the ability to tune 
properties within a family due to the synergic interactions between 
the varying functional groups on the constituent peptides.  
Natural dipeptides, such as carnosine (Car), (β-Ala-L-His) have 
been reported in the construction of MOFs (Table 2, entry 10). The 
carnosine chain contains and extra CH2 group due to the β-amino 
acid structure of the β-alanine, and an additional metal binding site 
can be found from the histidine residue which incorporates an 
imidazole moiety, therefore giving carnosine two more potential 
linking sites compared to GlyThr and GlyAla. [108] In the ZnCar∙DMF 
3-dimensional bio-MOF, each carnosine links four tetrahedral Zn 
cations, and two of those cations are bridged by the deprotonated 
imidazolate ring, forming a microporous material (please see section 
5 for more details). 
The incorporation of different functional groups in peptides can 
be achieved in most cases through simple synthetic routes. This 
strategy was adopted in the formation of GlyHis, a peptide 
containing carboxylate, amine and imidazole functional groups, with 
two different coordination modes around two different metal 
centers. The structure of the NiII framework consists of 1-
dimensional chains along the a and b-axes, with two imidazolate N 
atoms coordinated to the Ni affording an octahedral geometry 
around the metal center (Table 2, entry 11). [109] Interestingly, 
unlike a lot of peptides, the carboxylate group in this framework does 
not participate in metal binding, and is therefore protonated. This is 
also observed in the framework with CuII, which has square 
pyramidal geometry and is coordinated to three N atoms, thereby 
forming 1-dimensional chains along the b-axis (Table 2, entry 12).  
Recently, work has focused on rigid and flexible metal-dipeptide 
frameworks (some previously discussed), that show permanent 
porosity, and demonstrate interesting adsorption properties with 
the ability to be synthesized with a variety of different functional 
groups. However, it is difficult to tailor dipeptide MOFs with all the 
desired attributes, such as water stability, which is a hot topic in 
metal-peptide polymer chemistry. [110] Earlier this year, Bronić et al. 
designed a new metal-dipeptide MOF with a relatively large side 
chain, that would impose stability on the synthesized product, 
affording a MOF with enhanced properties such as water and greater 
thermal stability, as well as structural flexibility. [110] The crystal 
structure of [Zn(Gly-L-Phe)2] (Table 2, entry 13) consists of a 
tetrahedrally coordinated ZnII metal center coordinated twice via the 
amino groups of the Gly component, and twice via the carboxylate 
functional groups of the Phe. [110] Here, both sets of functional 
groups are coordinated in a monodentate fashion. In comparison, 
[Cd(Gly-L-Phe)2] (Table 2, entry 14) contains a hexacoordinated CdII 
comprised of four dipeptide ligands where the two ligands are 
coordinated through the Gly amino functional groups, and the 
carboxylate groups coordinate to the Phe moiety through a 
bidentate mode. [110] 
It should be noted, that the use of a tripeptide, GlyGlyGly, 
published by Marsh et al. was the first example of a bio-MOF 
containing more than two amino acids (Table 2, entry 15). [104] 
Interestingly, from a structural point of view, it is similar to 
Takayama's [Cd(GlyGly)2] at pH: 9. [101] Here, [Cd(Gly3)2] contains 
octahedrally coordinated Cd metal ions ligated by six peptides: the 
N-termini of two peptides provide two nitrogen ligands, with one 
oxygen from each of the four terminal carboxylates providing four 
ligands. [104] Each carboxylate group bridges two CdII metal ions 
forming 1-dimensional framework with chains eight-membered 
rings, the second-dimension is formed via the backbone of the 
peptide where the (Gly3) moiety adopts an extended confirmation: 
two peptides run antiparallel to each other affording a closed ring 
through the coordination of two CdII ions. [104] They also explored 
how the introduction of chirality would modulate the structure of the 
metal-peptide framework, which was accomplished by examining 
[Cd(Ala)3] (Table 2, entry 16). This bio-MOF formed a 1-dimensional 
extended molecular chain that was comprised of a series of rings 
linked by CdII ions. [104] Similar to the (Gly)3 structure, two (Ala)3 
peptide linkers in an antiparallel fashion bridge between two Cd ions 
forming a ring. Interestingly, due to the folding of the peptide 
terminal nitrogen group of the Ala moiety, the methyl groups are 
  
 
 
found pointing into the central cavity of the ring forming a 
hydrophobic pore. [104, 111] Meanwhile, the methyl groups of the 
second and third residues face outwards, these interact with the 
methyl groups of the adjacent methyl-peptide chains affording 
another hydrophobic contact which propagates through the 
structure in the second-dimension. [104] The work of the authors 
reinforces the idea of the possibility to engineer the properties of 
extended networks through the choice of amino acid side chains.  
Protein folding has been reported in a 2014 paper by Fujita et al. 
who constructed a short peptide with 3-py groups with amide bonds 
in the short peptide Gly-Pro-Pro (Table 2, entry 17). [112] Single 
crystal X-ray analysis clearly reveals that the peptide ligand is fixed in 
a PII helix conformation with all ligands linked by a py-AgI-py 
coordination similar to natural polypeptide chains (N→C direction 
terminal manner). [112] The linear helical strand of the MOF repeats, 
affording a unique hexagonal entanglement in the crystal giving a 3-
dimensional honeycomb network. [112]  
 Recently, Rosseinsky et al. reported two isoreticular 3-
dimensional peptide-based porous frameworks with Gly-L-His-Lys 
and Gly-L-His-L-Gly to CuII (Table 2, entries 18 and 19, respectively) 
which displayed higher solvent accessible volumes (47 % and 60.2 %, 
respectively), than previously reported with shorter dipeptides. [113] 
Upon desolvation both undergo structural collapse, however, they 
exhibit sponge-like amorphous-to-crystalline transformation when 
exposed to water, recovering their open porous framework. During 
desolvation, the frameworks are not porous to CO2, and both 
frameworks exhibited very low uptakes at 195 and 298 K at 1 bar and 
10 bar respectively. [113] 
Yaghi et al. reported the synthesis of fibers based on Cd linked 
with the pentapeptide NH2-Glu-pCO2Phe-pCO2Phe-Ala-Gly-OH, 
(Table 2, entry 20), in which two infinite CdII chains were linked by 
the peptide in a double-ladder fashion and proliferate along the 
longitudinal axis of the fibers. [114] The structure has the terminal 
Glu amino acid reacting in an intramolecular fashion to form a 2-
pyrrolidone moiety in the assembly process. Here, the Cd binds the 
ligands through both the pCO2Phe and Gly moieties, [114] with the 
pCO2Phe moiety bridging between the two CdII ions and a 
monodentate coordination mode through Gly. [114] The structure is 
further stabilized by a complex net of intra- and inter-molecular 
hydrogen bonding, where the amide bonds of the stacked ligands 
stabilize the double ladder (intramolecular). [114] While 
intermolecular hydrogen bonding occurs between water ligands and 
the 2-pyrrolidone carbonyl, the non-coordinating carboxylic 
component in the amino acid of pCO2Phe and terminal carboxylate 
of the entire structure, and finally between then 2-pyrrolidone amide 
and the non-coordinating carboxylic component of pCO2Phe which 
are donor-acceptor hydrogen pairs, further acting as a secondary 
interaction in the formation of the macroscopic structure. [114] 
3.3. Nucleobases 
Nucleobases are suitable bio-ligands for the design and synthesis 
of metal-organic supramolecular arrays due to their large number of 
oxygen and nitrogen donor sites of different basicity. This is a strong 
motivation to employ nucleobases for the formation of bio-MOFs as 
they have the potential to form numerous interactions, including 
coordination bonds, hydrogen-bonds and π-π stacking interactions. 
The multifunctionality and variety of binding modes in nucleobases 
within a structure can give rise to structural flexibility as seen in 
biological molecules such as proteins and peptide based frameworks. 
Transition metal complexes containing nucleobases have also been 
studied in order to explore the DNA-metal binding processes which 
are vital for the development of new biologically active metallodrugs. 
With the added benefits of being biologically and environmentally 
friendly, they are also naturally abundant and easy to produce, 
thereby keeping industrial costs low. To date, the most commonly 
reported bio-MOFs are based on Adenine (Ade). [52, 115-120] 
Despite the advantages, bio-MOFs containing nucleobases are 
not exhaustive, which may be the result of no control over their 
binding modes to metal ions, and their inherent lack of symmetry 
which inhibit packing in the formation of crystalline materials. Most 
of the examples reported in the literature highlight the rich 
coordination modes of Ade leading in the formation of highly porous 
bio-MOFs. Ade has five N atoms with different basicity; two 
pyrimidinate N1 and N3, two imidazolate N7 and N9 and one amino 
group N6 and all are available for metal coordination. Ade can be 
then mono-, bi-, tri-, or tetradentate coordinating ligand within the 
bio-MOF structure through [N3], [N9], [N3, N9], [N7, N9], [N1, N9], 
[N1, N7], [N3, N7], [N3, N7, N9], [N1, N6, N9], [N2, N6, N9] or [N1, 
N3, N7, N9] (Table 3, entries 1-20). [121-129] 
Rosi et al. demonstrated that the use of a symmetric zinc-
adeninate secondary building unit can overcome problems such as 
undesired coordination modes between Ade and metal ions, while 
increasing symmetry. [52, 115] The first nucleobase bio-MOF with 
formula of  [Zn8(Ade)4(bpdc)6O∙2Me2NH2]∙8DMF∙11H2O was 
composed with eight ZnII ions linked to four Ade ligands via [N1], 
[N3], [N7] and [N9] coordination modes, and infinite ZnII-Ade 
columns made of apex sharing ZnII-Ade octahedral cages. [52] This is 
compared to [Co2(Ade)2(COOCH3)2]∙2DMF∙0.5H2O, which consists of 
CoII-Ade-acetate paddlewheel clusters made of two CoII ions bridged 
by Ade via N3 and N9 coordination, and two acetate ligands. [115, 
130] [Co2(Ade)2(COOCH3)2]∙2DMF∙0.5H2O is built by further linking 
the clusters to Ade via [N7] coordination, and has cavities that are 
periodically distributed.   
 The versatility of Ade as an organic ligand has continually proven 
itself to be a key in designing multidimensional frameworks. In 
combination with aliphatic monocarboxylic acids and CuII, the 3-
dimensional, robust open frameworks [Cu2(μ3-ade)2(μ2-
OOC(CH2)nCH3)2]3∙xH2O [n from 0 (acetate) to 5 (heptanoate)] can be 
constructed using inexpensive reagents. [131] The basic building unit 
of these bio-MOFs is a center symmetric dimer where two carboxylic 
ligands (µ-O,O' coordination mode) and two Ade ligands ([N3] and 
[N9] atoms) are coordinated to two CuII atoms forming a 
paddlewheel unit. [131] Ade displays a tridentate coordination mode 
µ-[N3, N7, N9], due to the cross-linking of units through the 
coordination of the [N7] atom in the adeninato ligand to four 
adjacent entities with a 5.97 Å Cu∙∙∙∙Cu separation across the 
imidazole N9/N7 bridge. Hydrogen bonding interactions between 
the [N6]-H6A group of the Hoogsteen face of the nucleobase and the 
coordinated O atom of the carboxylic ligand reinforces the linkage, 
as well as forms a R11 (7) ring. [131] 
Similar to amino acids, Ade was mixed with a carboxylic acid and 
CdII  (IN: isonicotinic acid) in order to isolate a porous bio-MOF. Kang 
and Wang reported a new 3-dimensional bio-MOF 
[Cd2(Ade)2(IN)2(DMF)(H2O)]·DMF with a cadmium-adeninate 
paddlewheel subunit (Table 3, entry 14). [132] Within 
[Cd2(Ade)2(IN)2(DMF)(H2O)] ·DMF, there are two cadmium (Cd1 and 
Cd2) atoms; one is square-pyramidal (Cd1) with four different 
nitrogen atoms (Ade) and one oxygen atom (IN), while the other 
(Cd2) is octahedrally coordinated with three oxygen atoms (one 
  
 
water, one DMF molecule and one carboxylate from IN), and three 
nitrogen atoms ([N7, N3, N9] from Ade, and N from IN). [132] 
Adenine acts independently as a µ3-linker to bridge three Cd atoms, 
and the structure consists of a cadmium-Ade paddle-wheel units, in 
which two Cd1 atoms are bridged by four Ade. [132] The Cd2(Ade)4 
units are further bridged by Cd2 atoms to form a chain along the a 
axis. [132] The axial position is occupied by two pendent IN ligands, 
while one links two adjacent Cd2 atoms to form a chain, and the 
other coordinates a Cd1 atom by acting as a pendent ligand. [132]  
To overcome the disadvantage of low symmetry, the 
introduction of a highly symmetric co-ligand has proven to be useful 
strategy for the introduction of nucleobases into MOFs. [133] Within 
Zn3[Zn2(μ2-H2O)]3(Ade)6(TATB)4(DMF), two distinctive building units 
were identified in the structure due to the multiple binding modes of 
Ade. The first building unit contains two adenines which are linked 
by a four-coordinated ZnII via the imidazolate [N7] atoms and two 
carboxylates. [133] In the second building unit, the binuclear ZnII unit 
is bridged by two Ade ligands through [N3, N9], at the two equatorial 
positions, while two carboxylates coordinate at the two axial 
positions. [133] One-dimensional Zn-adeninate chains were formed 
with adeninate connected to both building units in a 1:1 ratio. [133] 
In each adeninate, it should be noted, that the [N7] donors 
coordinate to the first building unit, the [N3], and [N9] coordinate to 
the second building unit and the [N1] and [N6] atoms were 
uncoordinated. [133] 
Using CoII, Ade and aromatic tetracarboxylic acids H4TCPB and 
H4BTeC, 3-dimensional bio-MOFs were composed. [121] [Co3(μ6-
TCPB)(μ4-H2TCPB)(Ade)2]·H2O is a compact network, in which three 
CoII ions are bridged by two bidentate Ade ligands through [N3] and 
[N9]. [121, 134] [Co2(Ade)(μ6-BTeC)(μ-H2O)(H2O)2]·4(H2O) is 
comprised of bidentate Ade ligands forming binuclear CoII clusters 
through both the [N3] and [N7] sites, leading to 1-dimensional CoII-
Ade chains. [121, 134] The latter structure is shown to have 
reversible structural transformations upon removal and addition of 
H2O, giving a color change from pink to purple, respectively.[134] The 
indication of a color change implies a change in the coordination 
geometry of CoII from an octahedral to tetrahedral upon removal of 
coordinated H2O. [134-137]  
While the above examples highlight the rich coordination modes 
of Ade leading in the formation of highly porous bio-MOFs, 
nucleobases such as Gua and their derivatives, are known to form G-
quartet, and G-quadruplexes structures which have emerged as 
powerful tools for developing nanoscale porous materials and 
devices. [138-145] Verma et al. reacted N9-allylguanine and N9-
propargylguanine with cupric halides to form three structures 
ranging from discreet trinuclear motif to a mixed valence 
coordination polymer (Table 3, entry 16). [146]  
The first existing example of a crystallographically characterized 
nucleobase-incorporated metal-organic polyhedron (TMOP-1, Thy-
incorporated MOP) has also been reported by Zhou et al. (Table 3, 
entry 17). [133] Block crystals of TMOP-1, Cu24(MDPI)24 
(DMA)4(H2O)20 were obtained, and following XRD analysis, they 
found two types of Cu2-paddlewheel secondary building blocks in the 
structure due to different coordinating solvents at the axial position 
of the Cu2-paddlewheels on the exterior surface of the cage. [133] 
Packing of TMOP-1 could have been facilitated by the coordination 
of a DMA molecule, forming a π-π interaction pair with the 
synthetically attached Thy in the isophthalate moiety, from an 
adjacent MOP. [133] As well as through hydrogen bonding between 
two adjacent Thy molecules from two different MOPs. [133] 
3.4. Saccharides 
Cyclodextrins (CD) are α-1,4-linked cyclic oligomers of 
glucopyranose, which commonly fall into α-CD, β-CD and γ-CD, 
containing six, seven and eight glucopyranose units respectively. 
[147], [148] The structure of the cavity is toroidal, containing an 
apolar cavity with primary hydroxyl groups lying on the outside while 
the secondary groups are inside. Their ability to form inclusion 
complexes has been exploited in various areas of research (including 
MOFs) for drug carrier systems, the food industry, cosmetics and 
more. [149] The guest-host complex formation factors with organic 
molecules are Van der Waals, hydrophobic interactions, size effects 
and hydrogen bonding. [149] 
Saccharides, such as CD, are appealing bio-ligands for the 
construction of bio-MOFs as they can be prepared entirely from 
edible ingredients. For example, the synthesis of γ-CD can be 
synthesized using a salt substitute (KCl) in bottled water and 
Everclear grain spirit. [150] γ-CD is mass produced enzymatically 
from starch, and comprised of eight asymmetric α-1,4-linked D-
glucopyranosyl residues. [150] These bio-ligands are linked by 
potassium ions to form a symmetrical cyclic oligosaccharide, which 
forms a body-centered cubic structure. The symmetrical 
arrangement in γ-CD of eight asymmetric α-1,4-linked D-
glucopyranosyl residues is thought to be a key parameter for the 
construction of CD-MOF-2 by Stoddart et al. who reported their 
exploitation of γ-CD as a multidentate organic ligand to form 
functional bio-MOFs with the empirical formula [(γ-CD)(MOH)2] 
(where M: KI or RbI). [150] Overall, six γ-CD units of the (γ-CD)6 cube 
are held together by four K+ ions that are associated with the C6 OH 
groups and the glycosidic ring oxygen atoms of four α-1,4-linked D-
glucopyranosyl residues on the primary face of the γ-CD tori. [150] 
The (γ-CD)6 cubes are coordinated to four K+ ions to the C2 and C3 
OH groups of the other residues on the secondary faces of the γ-CD 
tori.[150] Therefore, each K+ ion is eight-coordinated with two 
primary OH groups, two glycosidic ring oxygen atoms and four 
secondary OH groups.[150] 
Stoddart et al. reported a six-membered cyclic variant, α-
cyclodextrin (α-CD) with RbOH to form long needles with hollow 
interiors – CDMOF. [151] The hollow nature of the α-CD based MOF 
is a rare example of a solid-state material containing sorting domains 
and porosity on both the nanoscopic and macroscopic scales. 
Structurally, the Rb+ cations are linked to the α-1,4-D-Glup residues 
through the C2, C3, and C6 ring oxygen atoms on their primary and 
secondary faces, however not every residue in the α-CD ring is 
coordinated to a Rb+ cation. [151] There are two different 
coordination modes present, one in which four α-1,4-D-Glup residues 
interact with the Rb+ cation and the other where five interact. 
Furthermore, the bio-MOF consists of three different 4-, 8- and 10-
coordinated SBUs. [151] Both the 8- and 10-coordinated SBUs have 
similar arrangements in their α-1,4-D-Glup residues, however it is 
speculated that the two O atoms that are not part of any α-ring in 
the 10-coordinate SBU correspond to OH- counterions  associated 
with Rb+ counterions or lingering H2O molecules remaining from the 
synthesis of the material. [151]    
Recently, Maspoch et al. have described the first coordination 
polymer made of octakis-[6-deoxy-6-(3-mercaptopropanoic 
sodium)]-γ-cyclodextrin and CuII, here after referred to as Cu-SD, that 
shows selective water-induced reversible structural transformations 
(Table 4, entry 2). [152] Here, SD is an octacarboxylate γ-CD in which 
one of the eight C6 hydroxy groups has been exchanged with sulfuryl 
  
 
 
propionic acid, which was initially proposed to strengthen the bonds 
between the CD ligand and metal ions. [152] The 
[Cu4(SD)(H2O)4]·46H2O material crystallizes into a 2-dimensional 
structure comprised of dinuclear Cu2(OOC)4(H2O)2 paddle-wheel 
clusters, with all CuII adopting a square base pyramid geometry 
coordinated to four oxygen atoms from four carboxylic groups, and 
one water molecule occupying the apical position. Crystals dried at 
room temperature rapidly lost guest molecules undergoing a 
structural transformation observable through the development of 
cracks in the solvated crystals. Powder X-ray diffraction revealed a 
shift and a widening of most of the peaks indicating a loss in 
crystallinity. However, upon immersion in water, the resulting 
crystals recovered their initial phase. Remarkably, crystals soaked in 
other solvents (acetonitrile, ethanol, and DMF) did not result in a 
reversible transformation, indicating that this bio-MOF is selective 
only to water. [152] 
4. Porous bio-MOFs 
While MOFs have emerged as an extensive class of crystalline 
materials, their attractive properties such as crystallinity, variability 
of both the organic and inorganic components within their structure 
and high porosity make them appealing for a plethora of 
applications. [153] Many of their applications hinge on important 
properties of MOFs: porosity, stability, tailored pore surface and 
crystallinity. [154] Porous MOFs are the bread and butter of 
applications such as adsorption/desorption of gases (gas storage), 
gas separation, ion exchange, enantiomer separation and selective 
catalysis. Permanently porous material is generally required for 
enantioselective separation and/or catalysis. Generally, challenges 
associated with porosity are linked to the host or framework stability 
upon removal of coordinated to the metal center solvent molecules 
or in the removal of guest molecules, with both still remaining 
synthetically challenging to “design” and construct robust and 
porous MOFs for reversible adsorption and desorption of guest 
molecules (e.g. gas storage and catalysis) while they retain their 
crystallinity. [155] 
Zhang et al. reported two homochiral ZnII based bio-MOFs 
constructed from D- or L-Ser, an amino acid that contains -OH, -COOH, 
and -NH2 polar functional groups and H2BDC. [94] For [Zn4(L-
Ser)2(BDC)]∙6DMF (referred to as 1-L), the homochiral structure 
chains built from enantiopure L-Ser and Zn are linked by achiral BDC 
ligands forming a rod-and-spacer motif with large rhombic channels, 
and the –NH2 group of L-Ser bridging two Zn centers with a Zn···Zn 
distance of 3.52 Å.[94] Each of the five-coordinate Zn centers 
(ZnO4N) has a distorted trigonal bipyramidyl geometry, connected by 
the L-Ser ligands into homochiral chains running along the c-axis.[94] 
The O atoms in the achiral BDC ligand occupy the equatorial positions 
of the homochiral chains, bridging these parallel chains to form a 
neutral 3-dimensional framework which has large channels running 
along the c-axis. [94] [Zn4(D-Ser)2(BDC)]∙6DMF (1-D) is isostructural 
with 1-L but with D-Ser incorporated in the structure instead of  L-Ser. 
Both 1-L and 1-D showed high storage capacity of CO2 at ambient 
temperature and is selective to CO2 over N2 and CO, which is 
associated to the presence of π-electrons of the ligands and the polar 
-NH2 groups, forming an electric field thereby inducing a dipole in 
CO2, leading to efficient interactions occurred between CO2 and NH2. 
[94] 
Most of the open bio-MOFs fall into the microporous category 
with pore sizes <2 nm. Enlarging their channel sizes to the 
mesoporous range (2-50 nm) remains challenging, with only a few of 
these frameworks containing mesoporous channels. [27, 115, 154, 
156-160] However, bio-MOF-100 with a formula of 
Zn8(Ade)4(BPDC)6O2∙4Me2NH2∙49DMF∙31H2O was found to be 
porous with BET surface area of 4300 m2/g, and low crystal density 
(0.302 g/cm3). The shape of the N2 isotherm collected at 77K (type 
IV) suggests that bio-MOF-100 has interconnected mesoporous 
channels running throughout the structure with a pore volume 
exceeding 4 cm3/g. [3, 115] The structure consist of zinc-adeninate 
octahedral building units (ZABUs) with eight zinc cations, four Ade 
ligands, and two apical oxo groups bridging two Zn cations together. 
 
Figure 1:   Isoreticular series bio-MOF-100 to -103, with increasing pore size 
based on systematically changing and increasing ligand size. a) and b) SBU of 
bio-MOF-100 and illustration of ligand exchange, c) N2 isotherms with surface 
areas ranging from 2704-4410 m2/g, color coding: Bio-MOF-1 (navy), Bio-
MOF-100 (red), Bio-MOF-102 (green) and Bio-MOF-103 (orange). (© 2013 
American Chemical Society, reprinted with permission) [161] 
[115] Twelve BPDC linkers connect each cage to four neighboring 
cages, which is repeated in the framework generating large cavities 
in the structure and solvent channels measuring about 28 Å in 
diameter. [115] The ZABU units further adopt a distorted truncated 
tetrahedron topology with two angles of 100.01o and two angles of 
130.73o, therefore, these ligands do not pack into an ideal diamond 
lattice, but they adopt an augmented LCS topology, and an open 
structure. [115] These characteristics distinguish bio-MOF-100 from 
bio-MOF-1, which has a framework comprised of infinite columnar 
stacks of apex-sharing ZnII-Ade octahedral units, with a BET surface 
area that is smaller (1680 m2/g).  Rosi et al. reported new isoreticular 
analogues of bio-MOF-100: bio-MOF-101, -102 and -103 (Figure 1). 
[161] This was the first demonstration of systematically increasing 
the pore dimensions using ligand exchange in bio-MOFs which 
represents a universal method for increasing the porosity in MOFs 
while avoiding interpenetration (provided the original MOF is also 
non-interpenetrated), and allowing access to bio-MOF materials that 
may be thermodynamically unfavorable. [161] The ligands NDC (bio-
MOF-101), ABDC (bio-MOF-102) and NH2-TPDC (bio-MOF-103, all 
with type IV adsorption isotherms) were used to methodically 
increase the pore size, and while this is an isoreticular series of MOFs, 
the exchange of ligands is possible due to the fact that ZABUs are 
very stable. [161] As expected, bio-MOF-102 and 103 have the 
largest pore volumes that exceed 4 cm3/g (4.36 and 4.13 cm3/g 
respectively) and bio-MOF-101 has the smallest pore volume of 2.83 
cm3/g.[161] This strategy demonstrates that ligand exchange can be 
used to increase pore size, creating a more porous isoreticular 
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analogue without sacrificing crystallinity. [161] Nucleobases have the 
ability to bind to metals through a variety of different donor atoms, 
leaving the non-coordinated atoms open, which can in turn be used 
to enhance the interactions within the pores of MOFs. For the spatial 
host-guest binding within a MOF, there are two prerequisites: 1) 
guest accessible nanoscale sized pores, 2) nucleobase residues are 
required to be immobilized on the internal surface, leaving the base-
pairing sites with open Watson-Crick faces. [162] Purine ligands are 
well-known for their ability to build binuclear complexes via their 
[N3] and [N9] bridging modes, and previous literature has 
demonstrated that Adeninate ligands can form paddle-wheel 
complexes, with the entities self-assembling via Watson-Crick ([N6]-
H, [N1]) and Hoogsteen faces ([N6]-H, [N7]) via π-π stacking.[163]  
  
Figure 2: a) Watson Crick (W-C) and Hoogsteen (H) face of Ade, b) Hydrogen 
bonding of Ade through both faces in the framework (© 2014 American 
Chemical Society, reprinted with permission), [163] c) the W-C face of Ade in 
ZnBTCA are pointing towards the pores and are readily available for 
hydrogen-bonding with Ade’s pair nucleobase, Thy.   (©2015 Wiley-VCH 
VerlagGmbH &Co. KGaA,Weinheim, reprinted with permission)[162] 
Thomas-Gipson et al. reported [Cu2(µ-Ade)4(X)2]2+ and [Cu2(µ-
Ade)4(µ-X)2(X)2]2+ (where X is either Cl- or Br-) metal-nucleobase 
binuclear entities to develop supramolecular bio-MOFs based on 
Watson-Crick and Hoogsteen hydrogen bonding interactions of 
adjacent Ade molecules. [163] The non-coplanar propensity of 
[Cu2(µ-Ade)4(X)2]2+ building blocks, afforded an open framework with 
1-dimensional channels of 6 Å, in both Cl- and Br- frameworks, that 
are sustained through the hydrogen bonding base pairing 
interactions of the Watson-Crick faces, while the [Cu2(µ-Ade)4(µ-
X)2(X)2]2+ synthons did not allow a 3-dimensional architecture based 
on such interactions between the nucleobases. [163] Instead, in 
[Cu2(µ-Ade)4(µ-Cl)2(Cl)2]2+·2MeOH, base pairing interactions 
produced an 1-dimensional supramolecular ribbon of binuclear 
entities, establishing additional hydrogen bonds between the 
Hoogsteen faces and the  Cl- of the adjacent ribbons, reinforced by 
the π-π stacking amidst the Ade, affording a robust microporous 3-
dimensional structure (Figure 2). [111, 163]  
Highly porous Ade-based bio-MOFs have been prepared using 
co-ligands of different mono-, di- and tri-carboxylic acids. [52, 111, 
115, 130, 161, 164, 165] This has also very recently been 
demonstrated by Li et al., reporting an Ade-based bio-MOF with 
formula of Zn3(Ade)(BTC)2(H2O)·(CH3)2NH2·xDMF·yH2O (denoted as 
ZnBTCA). The Watson-Crick faces (Ade-amino sites and neighboring 
pyrimidine N sites are vacant) of Ade within ZnBTCA are pointing 
towards the pores of the framework (Table 3, entry 15). [162] 
ZnBTCA contains 1-dimensional channels, and 68.5% void volume 
defined by the Connolly surface (used to visualize solvent-accessible 
surfaces), with a surface area of 3057.5 m2/g. [162] The Connolly 
surface highlights the guest-contacting regions of the open Watson-
Crick sites and the pendant carboxyl oxygen donors. [162] The 
channels are further interconnected giving an overall three-periodic 
pore connectivity, and the open Watson-Crick sites are aligned 
almost parallel to the contacting surface affording channel-
connecting windows. [162] Twelve organic dyes that are commonly 
used as DNA-staining agents (nucleic-acid research) are used, to 
explore the host-guest chemistry of ZnBTCA, which differed in 
dimensions, contacting sites, and ionic charges. [162] The authors 
reported that two guests, PfH+ and MB+ had special properties in 
terms of sorption kinetics. [162] Uptake experiments were 
performed and found that because of the size of MB+, which exceeds 
the minimum channel diameter of ZnBTCA, it is limited to surface 
sorption, whereas PfH+ takes priority with a moderate uptake 
amount. Since the channels are large enough to host both MB+ and 
PfH+, MB+ has uptake priority, indicating that the framework and PfH+ 
interact weakly, minimizing the uptake of PfH+. [162] In comparison 
to bio-MOF-1, ZnBTCA has smaller, less uniform channels and the 
uptake of guests is found to be much faster. [162] Furthermore, the 
hysteretic behavior of PfH+ is absence in bio-MOF-1 due to open 
Watson-Crick sites contributing to chemisorption host-guest 
interactions in ZnBTCA. [162] They further exploited this behavior for 
Ade-Thy (A-T as in RNA) binding within the constrained pores and 
found the host framework responded to the Thy binding, as 
supported indirectly by several pieces of consistent evidence. [162] 
The implications of their work may enable the boundaries of biology 
and material science to be extended.  
As described, the coordination chemistry of amino acids, 
peptides, nucleobases and saccharides is rich and MOFs with various 
structural topologies, different thermal/chemical stabilities and 
porosities have been constructed. However, bio-MOFs can be 
structural flexible or robust and they have been assessed for their 
potential in many areas including: a. CO2 capture, b. catalysis and 
separation, c. sensing and d. biological applications.  
5. Structural Flexibility and Robustness in bio-
MOFs  
The adaptability of the porosity of MOFs is limited by the metal 
coordination geometry and degrees of freedom by the ligands. [105] 
If the metal coordination geometry does not change, ligands are 
limited to configurations that are only accessible by uniaxial 
rotations. [105, 166] Differing from the classical rigid aromatic-based 
MOFs, ligands such as aliphatic peptides can access to extensive 
conformational space through low-energy torsions. [107] In 
response to environmental changes, protein folding can take place 
between well-defined structures that are associated with large 
atomic displacements. [167] Overall, peptides have many 
advantages such as the formation of flexible MOFs (comparable with 
protein folding), but depending on the interactions between the 
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layers/chains (via hydrogen-bonding), robust peptide based MOFs 
can be also generated.  
 
 
Figure 3: a) The packing of the 2-dimensional layered [Zn(GlyAla)2]∙(solvent)  
leads in the generation of pores running along c-axis, b) 13C (CP/MAS) NMR of 
the desolvated [Zn(GlyAla)2] showing a change in the peptide torsion angle c) 
CO2 isotherms collected at 273K and 15 bars show a sigmoidal shape – up to 
2 bar there is no uptake revealing that the pores are collapsed but after 2 bar 
there is a  gate-opening, d) representation of the deformation of the  
zn(glyala) upon desolavtion which is resulted from the torsion of the flexible 
glyala peptide (e) (© 2010 American Association for the advancement of 
Science, reprinted with permission) [105] 
A bio-MOF constructed with ZnII and the dipeptide ligand GlyAla, 
possesses conformational degrees of freedom as observed in protein 
folding. [105] The framework of [Zn(GlyAla)2]∙(solvent) is based on 
tetrahedrally coordinated Zn ions in which each Zn is coordinated to 
four dipeptide ligands; two dipeptide ligands are coordinated via the 
N-terminal Gly amine groups, while two are coordinated by the C-
terminal Ala carboxylate groups (Figure 3). [105] A grid like structure 
with layers is formed through the coordination of two zinc ions to 
each ligand. [105] The porosity has a complex topology defined by 
the side chains of the methyl groups in the L-Ala component of the 
dipeptide within the channels. [105] The polar methanol solvent that 
has been used as a solvent to construct this bio-MOF, occupies the 
pores interacting with the pore wall –carboxylate and amine groups 
via hydrogen bonding. [105] The 13C (CP/MAS NMR) of the 
desolvated [Zn(GlyAla)2] showed the expected five resonances, 
slightly shifted from the single crystallographically distinct peptide 
itself. However, the resonance corresponding to the methyl group 
splits into several resonances suggesting that the methyl group is 
surrounded by different chemical environments. In combination with 
the sigmoidal CO2 isotherms (gate opening) and simulations, it was 
concluded that the pores collapse upon desolvation. However small 
molecules with polar bonds such as CO2 and methanol trigger the 
pores to open gradually. [105] The adaptability of the pores is a direct 
effect of the peptide ligand, in which the four synergistic torsional 
degrees of the GlyAla permit the accessible void volume to be 
controlled by the methyl group. [105] 
 Deformation of the host framework, and the low energy states 
that are accessed, are characterized by cooperative torsions that are 
thermally accessible in the arrangement of the ligands in 
[Zn(GlyAla)2] by interactions of the coordinated metal center, and 
the hydrogen bonding in the rigidly planar amide unit hanging the 
ligand from GlyAla to GlyThr affords [Zn(GlyThr)2]∙MeOH, an also 2-
dimensional bio-MOF which displays 1-dimensional pores.[168] 
Here, ZnII has a distorted octahedral geometry and each ZnII metal 
center is coordinated six-fold by four dipeptide molecules. [168] Two 
peptides interact through the monodentate C-terminus of the Thr 
carboxylate group, and two other forming a five-membered N,O-
chelate with the amine and oxo groups of the N-terminus Gly 
residue. [168] Each GlyThr acts as a µ2-ligand, connecting two metal 
ions thereby forming 2-dimensional grid-like layers along the b-axis, 
whereas the 1-dimensional channels are packed along the a-axis, 
occupied by methanol guest molecules. [168]  
 
Figure 4:  a) top: open-to-closed SCSC transformation highlighting changes in 
peptide-to-peptide separation, bottom: square and rhomboidal (left and 
right, respectively) packing of both structures (before and after desolvation) 
viewed along the c-axis showing that the distances between metal centers d1 
and d2 decrease upon desolvation, b) structure of peptides used for the 
construction of mixed-peptide bio-MOFs c) CO2 isotherm at 195 K of mixed 
ligand systems with isosteric heats of adsorption (inset) for 
Zn[(GA)0.25(GT)0.75]2 (black), Zn[(GS)0.25(GT)0.75]2(blue), and  
Zn[(GS)0.50(GT)0.75]2(red) d) CO2 isotherms at 195 K of Zn(GA)2 (black), 
Zn[(GA)0.90(GS)0.10]2 (blue), Zn[(GA)0.75(GS)0.25]2 (purple), Zn[(GA)0.75(GS)0.25]2 
(red), Zn[(GA)0.60(GS)0.40]2 (dark green), Zn[(GA)0.50(GS)0.50]2 (light green). 
(©2014 Macmillan Publishers Limited, reprinted with permission). [107] 
[Zn(GlyThr)2]behaves as a "classically" rigid microporous 
framework due to the rigidity of the GlyThr ligand which is due to its 
conformation via intralayer hydrogen bonding, as well as the 
structure remaining unchanged upon activation. [168] 
Reinforcement of structural stability can be attributed to the -OH 
groups found in the side chains of the Thr amino acid, which enable 
inter- and intra-layer hydrogen bonding, overall favoring chelation 
between the metal ion and the peptide. [168] This reinforcement and 
interaction is specific to the Thr in the framework, and operates 
between adjacent layers providing the strengthened structural 
stability in three-dimensions, resulting in higher cooperativity. [168] 
Through these features the potential torsional flexibility of the 
peptide is locked.[168] It should be noted, that the additional 
hydrogen bonding between the adjacent layers is not present in 
[Zn(GlyAla)2], further confirming the enhanced rigidity of 
[Zn(GlyThr)2]∙MeOH. [168] 
a. b. c.
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Another bio-MOF [Zn(GlySer)2] has also been examined, and has 
been noted as isostructural to [Zn(GlyAla)2]·(solvent). [107] The 
incorporation of hydroxyl groups in the α-carbon position of the C-
terminus in the oligopeptide, thus imposes a different structure 
compared to the secondary hydroxyl group of the Thr in 
[Zn(GlyThr)2]. [107] The structure of [Zn(GlySer)2] is 2-dimensional, 
with layers built from stacking square like neutral [Zn(GlySer)2] 
sheets, which are formed by tetrahedral ZnII ions linked to four 
peptides which act as µ2-bridges. [107] Reposition of the OH-bearing 
side chain is associated with the torsional degrees of freedom of the 
Ser residue, which facilitates a significant translation displacement of 
the peptide. [107] Rosseinsky et al. went on to further mix ligands (in 
a multivariate (MTV)-concept) such as GlySer and GlyAla, this 
method of combining ligands with similar topology or metals to form 
MOF solid solutions and modulate their responsiveness and 
flexibility (Figure 4). [23] [169-173] The mixed-peptide based bio-
MOFs were isostructural with those when pure dipeptides were 
used, with peptide ratios determining the topology of the 
framework, whereas GlyAla/GlySer/GlyThr: 33/33/33 and 
GlyAla/GlySer: 50/50 ratios gave [Zn(GlySer)2]-like topologies. [107] 
At levels of doping ≥75% of GlyThr, GlyThr drives the formation of 
bio-MOFs with a [Zn(GlyThr)2] structure in GlyAla/GlyThr families, 
and at ≥50% in the GlySer/GlyThr series, while lower substitution 
levels adopt the [Zn(GlySer)2] structure. [107] Upon solvent removal, 
the effects of the hydrogen bonding in the Ser side chain are 
demonstrated by the structural change in isostructural 
[Zn(GlySer)0.75(GlyThr)0.25]2 affording a well-ordered material on the 
local level, whereas guest removal from [Zn(GlyAla)2] produced local 
torsional disorder of the GlyAla peptide. [107] Removal of guest 
molecules in [Zn(GlySer)0.75(GlyThr)0.25]2 brought about a cooperative 
single-crystal-to-single-crystal rearrangement of the framework 
from an open/solvated to closed/desolvated state. [107] Upon 
MeOH removal, the hydrogen bonds in the –OH side-chain are lost, 
with the resulting porosity not accessible, and lost hydrogen bonding 
restored via torsional changes in the GlySer ligand, enabling 
translational ordered displacements of the peptides. [107] The 
crystallinity transformation enabled by the flexibility of the GlySer 
ligand, which folds to occupy the empty space, reduces the void 
space to 2.9% in the closed state, compared to 22.0% in the open 
one. [107]  The conformational change upon guest removal (collapse 
of the structure) is attributed to the energetically favorable 
formation of intra-layer hydrogen bonds between the terminal -COO- 
and the -OH side chain on opposite faces of the channel wall. [107] 
These three examples highlight that charge on the side chains of 
peptides can lead in the construction of robust or flexible MOFs, 
therefore increasing the possibility to design flexible MOFs. They also 
have similar properties to previously discussed MTV-MOF series. 
 
 
 
 
 
 
 
 
Figure 5: a) Construction of (Co-L-GlyGlu) chiral rigid ladder, b) Replacement of the terminal coordinated H2O of Co-L-GlyGly with pillared ligands that vary in 
length, led in the generation of porous, homochiral MOFs Co-L-GlyGlu-pillar ligand, c) the CO2 uptake at 195 K and 0.8 bar of the isoreticular series increases 
upon using large ligands to link the Co-L-GlyGlu chains. Color scheme (only linker listed for clarity): bpeb (pink), azinebipy (green), azobipy (blue), bipy (red).  
(© 2015 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim, reprinted with permission). [65] 
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Carnosine (Car), with a molecular structure β-Ala-L-His is a 
natural dipeptide that it has been recently used for the construction 
of a new 3-dimensional flexible peptide based bio-MOF, ZnCar∙DMF. 
ZnCar is   permanent porous upon removal of the guest DMF (see 
section 3.2 for structural details) with a BET surface are of  448 m2/g, 
and it has an affinity to bind small molecules such as CO2 and CH4. 
[108] The flexibility is attributed to the hydrogen bonds formed 
between the dipeptide and guests, which lead to different torsional 
conformations of Car. [108] The structural stability in the presence of 
guest molecules proved to be adaptable, as the peptide 
conformation of ZnCar∙H2O and ZnCar∙MeOH changed without 
breaking the connectivity motif of 4:4 between Zn and Car. [108] 
Both MeOH and DMF were found to distort the framework locally by 
hydrogen bonding, but without generating a phase transition in the 
framework itself. [108] The loading and removal of MeOH into the 
ZnCar bio-MOF demonstrates that it can be reused. [108] 
   In 2006, Rosseinsky et al. reported the synthesis of a porous 
bio-MOF by connecting metal-amino acids (NiII-aspartate) layers with 
pillar ligands. However, the use of pillar ligands larger than bipy 
resulted in their crystallization within the pores of NiAspbipy, thus 
blocking the accessible volume for gas uptake. [174] The open-
framework [Ni2(L-Asp)2(bipy)]·1.28MeOH·0.72H2O, contains neutral 
chiral Ni(L-Asp) layers which are connected by bipy ligands affording 
a pillared 3-dimensional structure with 1-dimensional channels 
defined by the separation between the Ni centers in the Ni(L-Asp) 
layers, and the length of the pillar ligand. [174] The synthesis of 
[Ni2(L-Asp)2(azpy)]·(guests) showed a similar layered structure to that 
observed in [Ni2(L-Asp)2(bipy)] with a weight loss of 2.9% between 
30-200oC (solvent loss), and 70.9% between 350-800oC 
(decomposition of guest molecules and framework), as determined 
by thermogravimetric analysis. [89] The thermal stability of [Ni2(L-
Asp)2(azpy)]·(guests) is demonstrated by the high decomposition 
temperature. Replacing the bipy ligand with its respective derivatives 
(azpy, bpe, 3rbp, py3T and 35bpp), but longer bridging linkers, affords 
analogous materials with larger channels. [174] CO2 sorption 
isotherms were recorded on samples with the ligands azpy, bpe, 
35bpp and py3T, with the expectation that the materials would be 
permanently porous due to their robust backbones and solvent-
accessible volumes. [89] Unfortunately, even though the ligand size 
increased, the BET surface areas were very low and CO2 uptake was 
less than 0.5 % wt. [89] For the bio-MOFs based on azpy and bpe, the 
presence of large amount of ligands within the channels prevents 
access to guest species such as CO2 [89] The bio-MOF containing py3T 
was found to be intrinsically non-porous due to the bulky pendant 
pyridyl group projecting inside the channels, effectively eliminating 
porosity. [89] To eliminate the presence of excess ligands in the 
channels, restoration of porosity was achieved by sublimating the 
excess pillars ligands under high vacuum, which may be attributed to 
the high stability of the layered structures in these frameworks. [89] 
Interlayer spacing modification in the ligand (depending on pressure, 
temperature and guest molecules), suggests that the dimension of 
the channels could respond selectively and specifically to guest 
molecules. [89] 
While most of the examples previously described have provided 
researchers with insight on how to design robust or flexible MOFs, 
there is still a huge challenge to synthesize highly porous and robust 
peptide MOFs with control over pore size, and that can be used for 
separations such as gas capture. This was addressed by Maspoch et 
al. by following the pillar ligand strategy. The use of a peptide with 
two carboxylate and one amino functions, glycyl-L(S)-glutamate (L-
GlyGlu) with CoII, leads in the construction of a chiral and rigid ladder 
(Co-L-GlyGlu) that was used in reticular synthesis to link the ladders 
and induce porosity (please see section 3.2 for structural description) 
(Figure 5).[65] Replacing the coordinated terminal H2O molecules 
with pillar ligands with different length such as bipy (Co-L-
GlyGlubipy), azobipy (Co-L-GlyGluazobipy), azinebipy (Co-L-
GlyGluazinebipy) or bpeb (Co-L-GlyGlubpeb) afforded BET surface 
areas of 261 m2/g, 299 m2/g , 315 m2/g, and 601 m2/g, respectively, 
allowing for the assembly of porous homochiral MOFs from an 
originally non-porous structure. [65] The Co-L-GlyGlu units and their 
stacking are not affected by this process and subsequently the size 
of the pores is defined by the length of the pillar ligand used. [65] 
While these MOFs are stable in air or in common organic solvent, 
they are not stable in H2O (as they are hydrolyzed). 
 
6. CO2 Capture 
With environmental issues becoming one of the most pressing 
issues of our age, developing new materials for the selective capture 
of CO2 is alarmingly important. MOFs have emerged as promising 
materials for the selective capture and utilization of CO2.To date, 
research efforts have focused on generating open metal sites or 
incorporating ligands functionalized with Lewis basic groups; both 
strategies have shown to be promising for the selective capture of 
CO2 over other gasses such as N2 (flue gas) or CH4 (natural gas). [1, 
20, 28, 175-183] Bio-ligands can be decorated with multiple groups 
which can be incorporated into bio-MOFs which can be promising 
candidates for the selective capture of CO2. 
Adenine based bio-MOFs have shown to be good candidates for 
the selective capture of CO2, and this is attributed to the presence of 
Lewis basic sites that decorate their pore surface of bio-MOFs. [130, 
184] Post-synthetic exchange of extra-framework cations within bio-
MOF-1 was used by Rosi et al. to modify the pore dimensions, 
optimize its adsorption properties for CO2, and highlights the 
importance of cations present in the channels of Ade based bio-
MOFs.[185] The introduction of cations with different sizes: 
tetramethylammonium (TMA), tetraethylammonium (TEA) and 
tetrabutylammonium (TBA), into the pores led in the decrease of the 
pore volume and BET surface areas from 1680 m2/g for bio-MOF-1 to 
830 m2/g for the TBA loaded bio-MOF-1. [185] It is found however, 
that the CO2 adsorbed capacity did not scale with the pore volume or 
BET surface area, as the TMA loaded bio-MOF-1 adsorbed the most 
CO2 (4.5 mmol/g at 1 bar) followed by the TEA loaded bio-MOF-1 (4.2 
mmol/g at 1 bar) and the TBA loaded bio-MOF-1 adsorbed 3.41 
mmol/g at 1 bar. [185] At elevated  
temperatures (1 bar) bio-MOF-1 had the lowest CO2 capacity 
compared to those MOFs with TEA which had the largest capacity 
while both TMA and TBA loaded bio-MOFs were equally as effective. 
[185] It should be noted that the TBA loaded bio-MOF-1 was more 
effective as a CO2 sorbent compared to bio-MOF-1, even with half 
the pore volume and surface area. [185] At lower pressures (up to 
0.2 bar) small pore volume positively influenced the uptake of CO2. 
Through further investigation of the isosteric heats of adsorption, it 
is concluded that small pores lead to stronger interactions occurred 
between the loaded bio-MOF-1 with CO2. [185] 
   
While amine functionalization of a MOF has been proven useful 
for separating CO2 and N2, the Lewis acid-base interaction between 
NH2 and CO2 has also been shown to improve the selectivity of 
CO2/CH4 gas separations. [186] Rosseinsky et al. constructed 
[Ni3(pzdc)2(7Hade)2(H2O)4]∙(H2O)1.5 (where Hade: adenine and pzdc: 
3,5-pyrazoledicarboxylic acid) which is stable in standing in liquid 
water and air for at least 4 weeks. [187] The pH was modified to 5-7 
via metal ion concentration, allowing for the selective deprotonation 
of 9Hade [N9] compulsory to form the [N3, N9] bidentate bridging 
mode, and migration of a hydrogen to the neighboring imidazolate 
[N7], affording 7Hade coordination as a neutral terminal ligand. [187] 
In [Ni3(pzdc)2 (7Hade)2(H2O)4]∙(H2O)1.5, the NiII/7Hade/pzdc chains 
run parallel to the c-axis, and are linked in a 3-dimensional 
noncovalent network via hydrogen bonding and π-stacking. [187] 
The chains, based on a [Ni(7Hade)2]4+ blade dimer, are formed 
through the bridging coordination of the imidazolate [N9] and 
pyrimidinate [N3] atoms to two of the NiII. [187] The pzdc anion links 
the blade units and also bridges the two Ni cations in the 7Hade-
defined blade through a µ-O bridge from oxygen. [187] Furthermore, 
the pzdc completes the NiII coordination via an N16 chelate, forming 
the chain by the second pyrazole nitrogen N17 binding to a 
mononuclear NiII center which is also coordinated by the oxygen 
from the second carboxylate of the anion. [187] Therefore pzdc links 
NiII dimers via mononuclear NiII centers with each chain linked by two 
hydrogen bonds (one strong, the other weak) from the 7Hade amino 
group [N10], to two pzdc carboxylate oxygens and an N(10) p-π/π-π 
interaction between the 7Hade pyrimidinate rings. [187] Removal of 
the coordinated H2O ligands allows for the mononuclear NiII to 
become accessible from the principle channel space upon full 
desolvation. Exposure of the desolvated crystals to air for several 
minutes regenerates the original diffraction patterns, associated 
with the reversible atmospheric H2O coordination to the NiII. [187]  
Following desolvation, a BET surface area of 165.0 ± 4.2 m2/g was 
reported, and the isosteric heats of adsorption measure at 273 K and 
298 K for CO2 increased from 22.4 kJ/mol at 0.8% loading to 34.6 ± 
1.7 kJ/mol with an increase in CO2 loading (5.6% CO2 uptake). [187] 
These results are promising since a majority of porous materials 
show a decrease in isosteric heat of adsorption with an increase in 
CO2 loading, this is attributed to the occupation of the favorable sites 
within a relatively rigid structure. [187] Breakthrough experiments 
were conducted using a column packed with the material, where an 
equimolar mixture of CO2 and CH4 was passed over it. [187] The 
authors reported that CH4 was released at 129 s and after a delay of 
28 s CO2 was detected indicating a clear separation between the 
gases. [187] 
 For CO2 and N2 separation, bio-MOF MPM-1-TIFSIX 
[Cu2(Ade)4(TiF6)2], has been reported to have a high CO2 uptake and 
selectivity under ambient conditions and up to 1 atm, and can be 
synthesized from commercially available materials in a single step. 
[188] MPM-1-TIFSIX exhibited higher CO2 uptake compared to MPM-
1-Cl [Cu2(Ade)4Cl2]Cl2. Single-gas uptake of CO2, CH4 and N2 were 
reported for MPM-1-Cl as 44.2, 13.8 and 4.7 cm3/g, respectively, 
whereas MPM-1-TIFSIX uptake values are 89.6 cm3/g, 18.5 cm3/g and 
8 cm3/g. [188] The selectivity was analyzed using 10/90 CO2/N2 and 
50/50 CO2/CH4 binary mixtures, which mimic those found in post-
combustion and biogas purification, respectively. Separations 
increased six-fold and five-fold in CO2 selectivity when TIFSIX 
replaced Cl- (CO2/N2: 74.1 vs 12.5; CO2/CH4 20.3 vs 4.0) at 1 atm. [188] 
Materials that possess thermal and water stability are inherently 
more practical for CO2 separations, therefore MPM-1-TIFSIX was 
tested for those criteria. It was reported that the crystal structure 
was retained at 568 K and after immersion in water at room 
temperature for 24 hrs with minimal effects on CO2 uptake. [188] 
 
Table 5: BET, CO2 uptake capacities and Qst of selected bio-MOFs.  
 
* Langmuir Surface area 
--- Not listed 
 
Entry MOF BET (m2/g) CO2 (cm3/g) 
273K 1 bar 
CO2 (cm3/g) 
298K 1 bar 
Qst (1 bar, kJ/mol) 
(zero coverage)  
Ref. 
1 bio-MOF-1 1680 77/88 46/50 21.9/24.2 185 
2 bio-MOF-1 @ TMA 1460 101 60 23.9 185 
3 bio-MOF-1 @ TEA 1220 94 61 26.5 185 
4 bio-MOF-1 @ TBA 830 78 51 31.2 185 
5 GND+ @ bio-MOF-1 1640 108 57 28.8 191 
6 AmGND+ @ bio- MOF-1 1600 109 62 28.3 191 
7 DiAmGND+ @ bio-MOF-1 1500 115 68 29.4 191 
8 bio-MOF-11 1148 147 105 33.1 164 
9 bio-MOF-12 1008 100 71 38.4 164 
10 bio-MOF-13 412 60 45 40.5 164 
11 bio-MOF-14 17 45 31 --- 164 
12 II @ bio-MOF-14 N/A 92 N/A --- 190 
13 MPM-1-TIFSIX 809 --- 90 44.4 188 
14 MPM-1-Cl 30* --- 44 --- 188 
15 [Ni3(pzdc)2(7Hade)2(H2O)4]∙(H2O)1.5 165 --- --- 22.4 187 
16 TIF-A1 718 82 62 --- 124 
17 [Zn4(bdc)2(L-ser)2)]3∙6DMF 136.9 55.5 37.1 8.2 94 
18 [Zn4(bdc)2(L-ser)2)]3∙6DMF (1’-L-ht) 224.7 43.7 30.3 7.5 94 
19 [Zn(GlyThr)2]∙CH3OH 192 --- --- 15.8 168 
   
Rosi et al. further examined bio-MOF-11 and its isoreticular 
series bio-MOF-12, 13 and 14 which consists of an Ade linker with 
two free Lewis-basic sites (pyrimidinate N1 and the amino group N6). 
[165] It should be noted, that compared to other bio-MOFs, bio-
MOF-11 is still the best adsorbent for CO2 (capacity and selectivity). 
[189] The authors decorated the pores of bio-MOF-11-12-13-14 with 
acetate, propionate, burtyrated, and valerate, respectively, and the 
N2 and CO2 adsorption properties were then studied. As the length 
of the aliphatic chains increase, the BET surface areas decrease from 
1148 m2/g to 17 m2/g and the CO2:N2 mixtures range from 73:1 (bio-
MOF-11), 123:1 (bio-MOF-12) and 107:1 (bio-MOF-13) at 273K and 1 
bar (determined by ideal adsorbed solution theory calculations, 
IAST). [165] When the temperature was increased, the selectivities 
for bio-MOF-11-13 decreased to 43:1, 52:1 and 40:1, respectively. 
[165] The authors reported that bio-MOF-14 exhibits a molecular 
sieving property, allowing it to adsorb only CO2 at 273 and 298 K, and 
that there is no loss of crystallinity or porosity when the material is 
soaked in water for one month. [165] An ‘ideal’ material for CO2 
capture would combine the properties of bio-MOF-11 (high capacity 
for CO2 uptake) with that of bio-MOF-14 (high CO2:N2 selectivity and 
water stability). Implementing a design strategy, Rosi et al. targeted 
the core material of bio-MOF-11 for CO2 storage and the shell of bio-
MOF-14 to act as a gas sieve and shield the material against water. 
[190] A cobalt-adeninate core-shell structure with a porous mixed 
ligand core and a water stable bio-MOF-14 shell was successfully 
prepared by doping valerate into the bio-MOF-11 lattice. This further 
allowed for growth of the bio-MOF-14 shell and, after repeating the 
procedure three times, afforded II@bio-MOF-14, where II denotes 
the core C20.60C50.57 (with C2: acetate and C5: valerate). [190] The 
hybrid material adsorbed 30% more CO2 than bio-MOF-14 (44.8 
cm3/g) with a much lower N2 uptake at 77 K, suggesting that the shell 
efficiently prevents any significant N2 uptake by the core. [190] To 
confirm this, the material was ground, and found that a significantly 
higher amount of N2 was adsorbed at 77 K (108 cm3/g compared to 
54 cm3/g), thus it is likely that the N2 molecules have to pass through 
the bio-MOF-14 shell to enter the porous core. [190]  
In addition, the encapsulation of guanidium (GND+), 
aminoguanidinium (AmGND+) and diaminoguanidinium (DiAmGND+) 
within bio-MOF-1 was also studied and determined how this can 
impact on the CO2 adsorption properties, as well as their capacities 
and isosteric heat of adsorption. [191] These cations were selected 
because of their multiple Lewis basic sites, size comparability to 
DMA+ (pore volume does not significantly decrease after cation 
exchange in bio-MOF-1) and these guanidine derivatives have 
previously been studied as catalysts for CO2 chemical fixation. [192, 
193] Bio-MOF-1 and GND+@bio-MOF-1 had comparable BET surface 
areas and pore volumes (1630 m2/g, 0.70 cm3/g and 1640 m2/g, 0.70 
cm3/g respectively).[191] The encapsulation of larger cations: 
AmGND+@bio-MOF-1 and DiAmGND+@bio-MOF-1 have observed 
that the surface areas and pore volumes decreased slightly (1600 
m2/g, 0.68 cm3/g and 1500 m2/g, 0.66 cm3/g, respectively). [191] At 
273 K (1 bar) bio-MOF-1 adsorbed 88 cc/g, GND+@ bio-MOF-1 
increased to 108 cc/g, along with AmGND+@ bio-MOF-1 to 109 cc/g, 
and DiAmGND+@bio-MOF-1 adsorbed 115 cc/g (30% higher than 
bio-MOF-1). [191] Increasing the temperature to 298 K, 303 K, 308 K 
and 313 K, resulted in CO2 isotherms that followed the same trend as 
with those collected at 273 K, therefore concluding that for bio-MOF-
1, the CO2 adsorption can be enhanced with the introduction of Lewis 
basic molecules, and that these sites are beneficial for CO2 capture. 
[191] 
Recently, it has become of particular interest to create 
tetrahedral MOFs that would share structural topologies and 
coordination factors similar to zeolite chemistry. [194-197] 
Tetrahedral imidazolate frameworks (TIF) tetrahedrally coordinated 
with divalent cations (ZnII or CoII) by the uni-negative (when an atom 
only accepts one electron) imidazolate ligands. [198-202] A new 
approach was taken by Zhang et al. by adding an auxiliary uni-
negative ligand into a zinc-imidazolate tetrahedral assembly to 
generate tetrahedral frameworks with the formula Zn(Im)x(L2)2-x, 
where L2 is (Ade)(Int) in TIF-Al, (Im)3(Int) in TIF-A2 and (Im)(Int)2(OH) 
in TIF-A3. [124] The authors reported the construction of three new 
materials (TIF-A1, -A2, and -A3. Table 3, entry 6 and Table 5, entry 
16) with distinct topologies and mixed ligands. Interestingly, TIF-A1 
uptakes 82 cm3/g and 61.7 cm3/g CO2 at 273K and 298K respectively 
which is much higher than the current best performing zeolitic 
imidazolate framework (ZIF-69) (70 cm3/g). [124] This is attributed to 
the amine-functionalized imidazolate ligand, adeninate, 
incorporated within the structure. [124] In addition, the adsorption 
selectivity of TIF-A1 for CO2/N2 was measured as 17.5 at 273K and 
40.1 at 298K, they further measured adsorption isotherms of N2 and 
found hardly any adsorbed at all (4.7 cm3/g at 273K and 1.4 cm3/g at 
298K).[124] The selectivity for CO2 is thought to be attributed to the 
specific pore geometry in the structure, with possible interactions 
between CO2 and -NH2 in the pores. [124]  
Multidentate ligands, such as Ser, containing -OH, -COOH and -
NH2 have opened up a new approach towards CO2 capture and 
selective separation due to its special coordination mode. [94] It is 
demonstrated that bio-MOF [Zn4(BDC)2(L-Ser)2)]3∙6DMF (1-L-ht) has 
a lower uptake of N2 (42 cm3/g) and a higher uptake of CO2 (127 
cm3/g) which could be a result of the strong polar environment in the 
pores (see previous structure description of 1-L and 1-D). [94] The 
BET surface area was shown to be 136.9 m2/g, with a pore volume of 
0.063 cm3/g.[94] This bio-MOF however undergoes through a 
structural change upon removal of the DMF guest molecules. A 
similar material was prepared, where DMF was exchanged with 
MeOH by soaking the 1-L-ht crystals in MeOH for a week. The second 
DMF free MOF (1'-L-ht) had a maximum N2 uptake of 92.3 cm3/g, a 
BET surface area of 224.7 m2/g and pore volume of 0.081 cm3/g. The 
authors further explored the properties of both materials for CO2/N2 
separation under ambient conditions and found that the selectivity 
is 185:1 for 1-L-ht and 17.5:1 for 1'-L-ht. [94] From a structural 
standpoint, the gas adsorption selectivity could correlate with the 
existence of π-electrons in the ligands and the polar -NH2 groups. [94] 
Groups such as -NH2 and C=O in neighboring ligands provides the 
opportunity for interactions between both CO2 and N2, leading to an 
increased in lone pair polarization of the electron density in CO2. [94] 
This work highlights the importance of activation on porous 
materials as well as the impact of the pore geometry in the structure 
of [Zn4(BDC)2(L-Ser)2)]3∙6DMF. [94] 
   
 
Figure 6: a) Interlayer hydrogen-bonding interactions (dashed lines) (right), 
and grid-like space filling representation of [Zn(GlyThr)2] (left), b) CO2 
isotherm at 195 K – inset shows that [Zn(GlyThr)2] is selective to CO2 over CH4 
at 273 K and 10 bar.  (©2012 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim, 
reprinted with permission).[168] 
Bio-MOFs based on dipeptides, such as [Zn(GlyAla)2], have led to 
adaptable porosity, in which the pore conformation adapts to the 
loaded guest. [105] However, ‘rigid’ dipeptide ligands could play an 
important role in the next generation of biomimetic porous 
materials. [168] Rosseinsky et al. reported that the bio-MOF 
[Zn(GlyThr)2]∙CH3OH (Figure 6), behaves as a classic rigid porous open 
framework due to the conformational rigidity of the GlyThr ligand, 
which is driven by the hydrogen bonding intra-layer. [168] 
Adsorption isotherms revealed that CO2 was preferentially sorbed 
over CH4 with a single-component separation ratio of 14:1 (wt% : 
wt% at 1 bar). [168] Given the pore sizes of [Zn(GlyThr)2] (2.7-5.3 Å), 
it is shown that selectivity is not size-exclusive in origin, suggesting 
that a higher quadrupole moment of CO2 increased quadrupole-
dipole interactions with the amino/hydroxy groups found within the 
framework. [168]  
Reversible CO2 capture in MOFs can occur in two ways: 1) CO2 
binding to open metal sites, leading to materials with high selectivity 
for CO2, and 2) using weakly polar functional groups that bind CO2 by 
means of dipole interaction. [203] While both of these methods have 
their advantages and disadvantages, recycling CO2 has to be practical 
and not require more energy than necessary to regenerate the 
starting material. Inspired by weak nucleophilic functional groups, 
Stoddart et al. found that CDMOF-2 had an atypically strong affinity 
between CO2 and the MOF indicative of a chemisorption process (see 
section 3.4 for structural details). [203] At low pressures, the 
selectivity for CO2 over CH4 was nearly 3000-fold. [203] The steep 
slopes in the isotherms suggest covalent bonding, which was 
confirmed by the abrupt transition in high pressure regimes (>1 Torr) 
which becomes more dependent on temperature (30% greater 
uptake at 273K vs 298K). Therefore, at low pressures covalent 
bonding is preferential, giving way to physisorption at high pressures, 
with the change in mechanism occurring when the CO2 adsorbed by 
the MOF is approximately 23 cm3/g. [203] It is shown that the 
diffusion of CO2 into the extended framework of CD-MOF-2 resulted 
in the formation of alkyl carbonic acid functions on the γ-CD, by 
covalent bonding to non-coordinated free primary hydroxyl groups, 
affording CA-CDMOF-2. [204] While there has been a lot of data on 
CO2 sequestration, there has been only one report using colorimetric 
sensing, and no reports of electrochemical sensing of CO2 by bio-
MOFs and also in MOFs. [204] The authors employed 
electrochemical impedance spectroscopy to measure the changes in 
proton conductivity, and after observing a large drop in conductivity 
(approximately 550 fold) following infusion of CO2 in CDMOF-2, 
associated this with the impediment in motility of free protons. [204] 
Decrease in the conductivity of CA-CDMOF-2 can be attributed to the 
loss of coordinated hydroxide that catalyzes the deprotonation of 
the methanolic medium, blocking of hydrophilic triangular shaped β-
windows, therefore decreasing the mass transfer of the intermedium 
molecules. [204] Carboxylation occurs primarily in these windows as 
they are the only location of uncomplexed, primary alcohol 
functions. [204] CDMOF-2 was reported as having a high degree of 
reversibility, which occurs rapidly under mild conditions, liberating 
sequestered CO2. [204] Features like this one, are extremely 
attractive and important in the continuous reusability of bio-MOFs.   
7. Catalysis and Separations 
Bio-MOFs can be also considered as potential candidates for 
catalysis and separations. [75, 76, 174, 205-212] However, despite 
their rich chemistry, catalysis with bio-MOFs is scarce. [213] This is 
often associated with stability and cost in MOF catalysis which is 
suitable for fine chemical synthesis rather than bulk chemistry. [214] 
While this area of research still has room for growth, the ligands 
themselves offer conveniences such as pre-installed chiral centers 
for enantioselective separations and can give functional pores that 
can be used for many applications. In this section we will review 
heterogeneous asymmetric catalysis, enantioselective separations 
with the use of chiral peptide based bio-MOFs, and the separation of 
hydrocarbons.   
Rosseinsky et al. protonated [Ni2(L-Asp)2(bipy)]∙guest and [Cu2(L-
Asp)2(bpe)]∙guest (bpe: 1,2-bis(4-pyridyl)ethane) with HCl in Et2O to 
form the frameworks [Ni2(L-Asp)2(bipy)∙(HCl)1.8(MeOH)] and [Cu2(L-
Asp)2(bpe)∙(HCl)2(H2O)2]. [213]  The selective pore size of [Ni2(L-
Asp)2(bipy)∙(HCl)1.8(MeOH)] is due to the exceptional hydrogen 
bonding properties of MeOH, allowing it to overcome the 
framework···anion interactions allowing it to access the interior 
pores. [213] The HCl introduced into the framework denotes a full 
proton transfer to an aspartate carboxylate group forming a COOH 
moiety that is tethered to the metal center due to its confinement 
within the pore wall. [213] The structure of [Cu2(L-
Asp)2(bpe)∙(HCl)2(H2O)2] is porous to both MeOH and propylene 
oxide, however is non porous to CO2 (-78 oC). The post-synthetic 
modification introduced Brønsted acidic -COOH sites forming bio-
MOFs that were active as heterogeneous asymmetric catalysis in the 
methanolysis of cis-2,3-epoxybutane. [213] However, the materials 
displayed a modest chiral induction ability with the best results being 
17% e.e. for the methanolysis of cis-2,3-epoxybutane to 3-
methoxybutan-2-ol. [213] 
[Ni2(L-Asp)2(bipy)]·guest molecules, was tested in the extent of its 
enantioselectivity in guest sorption using a library of small chiral 
molecules with closely related functionalities. [174] It is reported 
that the opposite enantiomer was increased by sorption when a host 
derived from D-Asp rather than L-Asp was used, confirming that 
geometry-dependent interactions between the bio-MOF and chiral 
diols were present. [174] The highest report sorption e.e. value 
observed was 53.7 % for 2-methyl-2,4-pentane-diol, a mono-
substituted derivative of 2,4-pentanediol which had the second 
highest e.e. of 24.5 %, and a single chiral center. [174] Interestingly,  
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Figure 7: Coiled Gly-Pro-Pro peptide folded via a metal directing network 
(top). Space filling of the view within the whole framework, with the large 
nanopore A above smaller pore B (bottom, left). Table 2 shows the chiral 
recognition by channel A. R  and S enantiomers are selectively encapsulated 
in enantiomeric crystals of the [(AgBF4)∙Gly-D-Pro-D-Pro] material (entries 1-
2). Increasing the concentration of the racemate showed a decrease in 
enantiomeric selectivity (entries 3-4 and 5-6, for 50 mM and 100 mM, 
respectively). (© 2014 Wiley-VCH Verlag GmbH &Co. KGaA, Weinheim, 
reprinted with permission). [112] 
 
the derivatives with similar chain length, but different positions of 
the -OH group gave significantly different enantioselective sorption 
values. [174] Increasing the size of the ligand allows for the ability to 
introduce active sites into the pores. [65]  
As described earlier, Maspoch et al. reported a homochiral family 
of Co-L-GlyGlubipy bio-MOFs with varying pore volumes (0.188 cm3/g 
to 0.256 cm3/g) when pillar ligands of different sizes were used. [65] 
Activated samples were immersed in a solution containing racemic 
mixtures of either glycidol or hydrobenzoin at room temperature, 
and after 48 hrs the crystals were washed and dried, then immersed 
in anhydrous methanol to extract the adsorbed glycidol and 
hydrobenzoin. [65] The authors reported e.e. values of (S-glycidol 
over R-glycidol) 54.1 ± 1.0% for Co-L-GlyGlubipy, 38.2 ± 2.0% for Co-
L-GlyGluazobipy, 34.0 ± 1.5% for Co-L-GlyGluazinebipy and 38.7 ± 
1.0% for Co-L-GlyGlubpeb, which are inversely correlated to the total 
amount of adsorbed glycidol and the enantioselective adsorption of 
the S-form, with Co-L-GlyGlubipy exhibiting the highest e.e. but 
adsorbing the least amount of glyidol. [65] It was postulated that the 
smaller pore size promoted stronger interactions between the chiral 
pore-wall and glycidol.[65] To demonstrate that these bio-MOFs 
could adsorb S-enantioenriched glyidol or hydrobenzoin, the authors 
repeated the same glycidol adsorption process twice using Co-L-
GlyGlubipy, that had been previously loaded once with glycidol, and 
evacuated via immersion in methanol at 40oC. [65] In the second and 
third processes, the e.e. values (S-glycidol over R-glycidol) were 54.4 
± 1.0 % and 55.0 ± 1.5 %. The same process was repeated with Co-L-
GlyGlubpeb and hydrobenzoin, with reported e.e. values (S-glycidol 
over R-glycidol) of 28.8 ± 4.0 % and 25.6 ± 0.5 %. [65] These 
resultsconfirm that this isoreticular family of bio-MOFs is stable to be 
re-used for enantioselective adsorption, and that the adsorbed 
enriched molecules can be fully released. [65]  
The peptide Gly-Pro-Pro reported by Fujita et al. was modified by 
introduction of 3-pyridyl groups with amides bonds at both termini 
to produce a coordinative tripeptide ligand (structure previously 
described in section 3.2). [112] Through its slow diffusion into an 
aqueous solution of AgBF4, bio-MOF [(AgBF4)∙GlyProPro] formed 
with two types of 1-dimensional chiral channels running along the 
crystallographic c axis (Figure 7). [112] The largest channel is 
surrounded by the peptide backbone forming a left handed duplex-
like framework stabilized by π-stacking of the pyridyl groups, while 
the smaller second channel is closely packed with solvents and 
anions. [112] This includes independent BF4- anions, with one 
securely trapped at the terminal amide of the GlyProPro bio-ligand, 
and the other at the other at the terminal pyridyl group via C-H∙∙∙F 
hydrogen bond. [112] In the largest channel, a large degree of chiral 
recognition was reported when racemic compounds 1,1'-bi-2-
napthol was soaked in the single crystals of  [(AgBF4)∙GlyProPro] and 
encapsulated. [112] Analysis by chiral-phase HPLC indicated the R-
form was favorably encapsulated with 48% e.e. while the S-form was 
also selectively encapsulated after repeating the same process with 
the Gly-D-Pro-D-Pro ligand.[112] The observation of relatively high 
e.e. values is interesting considering that 1,1ʹ-bi-2-napthol is smaller 
than the nano-sized channel, therefore, the guest molecule 
differentiation is assumed to be occurring in the nano-sized peptidic 
helical channel on the interior surface. 
  Flexible MOFs exhibit favorable characteristics for the selective 
adsorption of light hydrocarbons with similar size. [215] One of the 
most challenging separations in the chemical industry is that of BTEX-
benzene, toluene, ethylbenzene, and the regioisomers of xylene, and 
while they act as antiknocking additives in gasoline, they are also 
critical chemical feedstocks, thus the need to separate and process 
them is essential. [216-221] Terephthalate-based MOFs with 1-
dimensional channels have been the most widely investigated in the 
separation of aromatic hydrocarbons, [222-226] in particular, both 
MIL-47 and MIL-53 have demonstrated high o-xylene selectivity 
based on entropic differences and molecular packing. [223-225, 227] 
Due to pore morphology, and commensurate stacking, both MIL-125 
and MAF- X8 have shown high p-xylene selectivity. [228] A flexible 
cerium tetradentate carboxylate MOF with restructuring driven by 
guest molecules, displaying molecular-level recognition for p- and m-
xylenes giving high selectivities, thereby adding to the increasing 
number of flexible MOFs that can be used for separations. [35, 223, 
229] 
Stoddart et al. recently reported a high selectivity of CD-MOFs (γ-
CD) (see section 3.4), which exhibited high shape selectivity, for 
separation of aromatic hydrocarbons using alkali metal cations. [215] 
The retention order of o- > m- > p-xylene separation was determined 
through adsorption isotherms and liquid-phase chromatographic 
measurements, with impressive regioselectivity of ethyltoluene and 
cymene regioisomers during the liquid-phase chromatography. [215] 
Furthermore, this work highlights the specificity of shape selectivity 
exhibited by CD-MOFs through the isolations of regioisomers of i. 
ethyl toluene,  ii. cymene together with the purification of cumene 
from major impurities such as benzene, n-propylbenzene, and 
diisopropylbenzene and iii. the separation of the industrial relevant 
BTEX. [215] Monte Carlo molecular simulations suggest the γ-CD 
rings enable selectivity for o-xylene through a favorable host-guest 
interaction, and efficient packing of the isomer in the framework, 
which is confirmed by the host-guest interactions from virial 
equation analysis of vapor isotherms. [215] For isomers such as 
cymene, their larger size and steric bulk can decrease their ability to 
form favorable orientations thereby culminating in weaker 
interactions with the framework, the 
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Coordination-Driven Folding and Assembly of a Short Peptide into
a Protein-like Two-Nanometer-Sized Channel**
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Abstract : Short peptide helices have attracted attention as
suitable building blocks for soft functional materials, but they
are rarely seen in crystalline materials. A new artificial
nanoassembly of short peptide helices in the crystalline state
is presented in which peptide helices are arranged three-
dimensionally by metal coordination. The folding and assem-
bly processesof a short peptide ligand containing theGly-Pro-
Pro sequence were induced by silver(I ) coordination in
aqueous alcohol, and gave rise to a single crystal composed
of polyproline I I helices. Crystallographic studies revealed that
this material possesses two types of unique helical nano-
channel ; the larger channel measures more than 2 nm in
diameter. Guest uptakepropertieswere investigated by soaking
the crystals in polar solutions of guest molecules; anions,
organic chiral molecules, and bio-oligomers are effectively
encapsulated by this peptide-folded porous crystal, with
moderate to high chiral recognition for chiral molecules.
Artificial protein-like functional nanostructures have wide
prospects for application in the sophisticated molecular
recognition processes and enzymatic reactions of bio-related
molecules. In natural systems, polypeptides containing dozens
to hundreds of residues are precisely folded into helices,
sheets, or turns, and then assembled into well-defined three-
dimensional structures. Proteins are often composed of
repeated sequences (tandem repeats),[1] and this can be
considered an efficient way to produce nanoarchitectures
from a limited amount of sequence information. Even in
artificial systems, only a small number of peptide residues
may ultimately be required for the rational bottom-up
synthesis of protein-like architectures through tandem
repeats. This idea prompted us to examine the self-assembly
of a short peptide fragment using coordination-driven self-
assembly, which is a powerful strategy for the construction of
well-defined artificial functional nanocavities.[2,3] However, in
contrast to conventional rigid ligands, oligopeptides are not
easily accessible for such a purpose owing to their conforma-
tional flexibility.[4] To overcome this difficulty, we found that,
in addition to networking, folding is an essential consider-
ation, as peptide helices are ubiquitously generated in nano-
structures.[5] Herein, we describe a new approach for the
creation of artificial protein-like nanocavities in which the
two key processes, networking and folding, work in concert
(Figure 1). The short peptide Gly-Pro-Pro (Gly : glycine, Pro:
l -proline), a sequence unit of collagen, was specifically fixed
in the polyproline I I helix (PII helix) conformation and, at the
same time, three-dimensionally networked by coordination-
driven self-assembly to afford a single crystalline nanostruc-
ture. A lthough previous examples of crystalline coordination
materials with short peptides have been reported, to the best
of our knowledge, this is the first report on such a material
composed of in situ folded peptide helices.[6,7] Moreover, the
helical peptidic conformations and their entanglements
generated through metal-coordination provide unique huge
nanochannel structures (diameter > 2 nm) in the framework,
and these were revealed to efficiently take up chiral
molecules and bio-related oligomers.
The short peptide Gly-Pro-Pro wasmodified to generate
coordinative ligand 1 by the introduction of 3-pyridyl groups
(py) with amide bonds at both termini. Tripeptide ligand
1 was synthesized in two steps of solution-phase peptide
synthesis (overall yield : 29%).[8] L igand 1 showed conforma-
tional flexibilit in solution: three major conformers were
confirmed by 1H NMR measurements (Supporting Informa-
tion, Figure S3). Circular dichroism measurements also
showed that the short fragment of Gly-Pro-Pro was present
in a conformationally denatured state in both water and
ethanol (Supporting Information, Figure S11). However,
when an ethanol solution of 1 (56 mm) was slowly diffused
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Figure1. Concept of this work. Random-coil peptide ligands are
concomitantly folded through metal-directed networking. Note that the
illustration of the network does not represent the network topology of
the complex in the present study.
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from the Gly-d-Pro-d-Pro ligand (entry 2, Table 1). When
amore highly concentrated solution (50 mm) of racemic 2was
used, about six molecules of 2 were trapped per helical pitch,
but the enantiomeric selectivity was reduced (35% ee,
ntries 3,4, Table 1). The number of trapped molecul s is
almost saturated at this concentration as treating the crystal
with a 100mmsolution of 2 (entries 5,6, Table 1) gave similar
results. The observation of relatively high ee values is
remarkable because guest 2 is considerably smaller than the
nanosized channel.[11] Thus differentiation of the guest
chirality presumably occurs on the interior surface of the
n nosized peptidic helical chann l.
Furthermore, large channel A is suited to the molecular
recognition of large bio-oligomeric molecules. Maltopentaose
3, a linear pentasaccharide c mposed of five d-glucose units
(Glc) with a(1! 4) linkages, was successfully encapsulated
within channel A . Guest encapsulation was carried out by
simply soaking the single crystals in a methanol solution of 3
(20 mm) for oneweek at room temperature. A fter the crystals
were separated from the mother liquor and decomposed by
addition of aqueous NaCl, the filtrate was characterized by
1H NMR spectroscopy. Themolar ratio of ligand 1and guest 3
was revealed to be approximately 10:1 by comparison of the
integral ratio of theGlcH1 signalsof 3and Pro Hb,gsignalsof
1 (Supporting Infor ation, Figure S24). Elemental analysisof
the crystals also supported the encapsulation of 3 within the
crystal at a ligand/guest ratio of around 10:1 (calcd. for
{[(AgBF4)·1]·0.1(3)·(H 2O)·(CH 3OH)}n: C 41.68, H 4.82,
N 10.80%; found: C 41.52, H 4.99, N 10.91%). These data
indicate that the space enclosed by two helical pitches of
channel A was occupied by four to five molecules of 3.[12]
Figure 4 shows the geometry-optimized structure of 3 within
channel A after a molecular dynamics simulation. However,
encapsulation of 3 was unsuccessful when aqueous buffer
(H2O-MeOH = 1:1 (v/v) with 50mmNaBF4) was used as the
solvent. This indicates that encapsulation of 3 within the
crystals is enthalpically driven: presumably, 3 is efficiently
trapped by hydrogen bonds between a number of hydroxy
groups on 3 and amide carbonyl moieties on peptide 1 along
_3B2>
Figure 3. Nanochannel structure in [(AgBF4)·1]n. a) Top view: within the
whole framework (blue stick representation), larger nanochannel A is
highlighted in green/magenta space-filling representation and smaller
nanochannel B in cyan/yellow. b) Side view: space-filling representation
of nanochannel frameworks A and B. One pseudo-strand (green or
magenta) is formed not by chemical bonds but by connection through
p-stacking of the py groups. Two such pseudo-strands form a left-
handed duplex-like structure (22.8 Š pitch). All solvents and hydrogen
atoms have been omitted for clarity.
Table 1: Chiral recognition of 2 by channel A.
Entry rac-2
[mm]
Crystal type[a] Uptake
[molecules/pitch][b]
S/R ratio[c] (ee%)
1 10 l 2.2 26.0/74.0 (R, 48)
2 10 d 2.4 74.2/25.8 (S, 48)
3 50 l 6.1 32.7/67.3 (R, 35)
4 50 d 6.0 67.7/32.3 (S, 35)
5 100 l 7.4 36.2/63.8 (R, 28)
6 100 d 7.4 63.3/36.7 (S, 27)
[a] Crystal of [(AgBF4)·1]n made from l - or d-peptide ligand 1. [b] Number
of molecules trapped in one pitch of channel A (based on the integral
ratio of ligands 1 and 2 in the 1H NMRspectrum). [c] Area ratio in chiral-
phase HPLC traces.
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Figure 8: Illustration of lanthanide incorporation into bio-MOF-1, including the encapsulation and sensitization of cations SmIII, TbIII, and EuIII (top). Lanthanide 
samples illuminated with a 365 nm laboratory UB lamp (left) and PXRD patterns LnIII@Bio-MOF-1 (bottom, center). EuIII0.005-TTA@bio-MOF-1 can further be 
used as a fluorescence sensor to detect volatile organic amines based on pH (right, bottom) (© 2015 Royal Chemical Society,[236] © 2011 American Chemical 
society,[240] both reprinted with permission). 
inability to discriminate between m- and p-cymene, as well as shorter 
retention times.[215] 
In 2016, Stoddart et al. further reported the ability to separate a 
wide variety of mixtures, including ethylbenzene from styrene, 
haloaromatics, terpinenes, pinenes, alkyl-, vinyl- and others, 
including chiral compounds, with CD-MOF-1. [230] The retention was 
influenced by i. the saturation of a compound, with those having a 
greater retention being saturated, ii. the placement of a double bond 
within the molecule, for example in the case of pinene and terpinine, 
isomers with an exocyclic double bond were more highly retained 
than their endocyclic counterparts. [230] Separations between 
mono- and di-substituted haloaromatic compounds were influenced 
by the size of the halogen substituent, and the strength between the 
analyte and framework through noncovalent bonding interactions. 
[230] Enantiomers of chiral analytes, including limonene and 1-
phenylethanol, could be resolved due to the homochiral framework. 
[230] With a wide variety of separation abilities, CD-MOF-1 is not 
only versatile, environmentally benign, and biocompatible, but it can 
be additionally used as a stationary-phase material for separations. 
Recently, Zhang and Fu constructed a microporous bio-MOF, 
[NH2(CH3)2][Zn3(4-Pca)3(Ade)]·10DMF·8H2O (Table 3, entry 20) which 
showed dynamic deformation with light hydrocarbons with large 
hysteresis and high capacity. [231] Adsorption of C1 to C3 paraffin’s 
at 273K showed that the material adsorbed up to 117.5 cm3/g of 
C2H2, 76.6 cm3/g of C2H4, 70.0 cm3/g of C2H6 and 70.7 cm3/g of C3H8 
at 294K and 1 bar; and 146.2 cm3/g of C2H2, 96.6 cm3/g of C2H4, 92.8 
cm3/g of C2H6, and 88.1 C3H8 at 273K at 1 bar. [231] Adsorption 
behaviors in response to the light hydrocarbons were taken into 
consideration, and the authors reported that gate-opening pressure 
point follows the order of C3<C2, while the lower gate opening 
pressure (as well as higher uptake capacity) of C2H2 over C2H4 and 
C2H6 is attributed to the smaller kinetic diameter and stronger 
interactions of C2H2 and the framework. [231]  
Martí-Gastaldo et al. reported a chiral CuII 3-dimensional bio-
MOF based on Gly-L-His-Gly (GHG) for the enantioselective 
separation of methamphetamine and ephedrine. [232] While both 
compounds are well known as recreational drugs, they are also 
components used in the preparation of therapeutics such as 
bronchodilators and respiratory stimulants. [232] Cu(GHG) is 
constructed through an interconnecting four-fold helicoidal Cu-
peptide-Cu chains via a µ2-carboxylate bridging C-terminal Gly, with 
porosity forming via interconnected 1-dimensional empty channels. 
[232] Post-synthetic modification of the peptide allows a variety of 
functional groups (carboxylate, amide, amino and imidazole) to be 
added to the surface of the pore with the groups pointing into the 
channel. The Cu(GHG) crystals display a sponge-like behaviour with a 
reversible crystalline-to-amorphous transformation after activation. 
Initial studies to recognize the selectivity were performed by soaking 
the bio-MOF in racemic mixtures of methamphetamine and 
ephedrine, resulting in a 30 ± 3 % and 37 ± 3 % adsorption of (+)-
methamphetamine and (+)-ephedrine, respectively. [232] These 
results are attributed to the preferential interaction of the (+)-
enantiomers in the chiral pocket of the bio-MOF that aid in hydrogen 
bond formation with the His side chain. [232] The authors further 
demonstrated the applicability of their work by packing 50 mg of 
Self assembly
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Cu(GHG) into a polypropylene SPE cartridge and eluded a racemic 
mixture of (±)-ephedrine in 75:25 ratio of hexane:ethanol at 0.25 
mL/min followed by HPLC. Quantitatively, 54 ± 2 % of (+)-ephedrine 
was separated from equimolar enantiomer mixtures, and the 
Cu(GHG) bio-MOF cartridges can be used for at least two runs 
without a significant loss of enantioselectivity. [232]  
8. Sensing Applications 
Fluorescence can be derived from highly fluorescent ligands or 
lanthanides, however to our knowledge there are currently no bio-
MOFs based on lanthanides. The luminescence property of 
lanthanide-functionalized MOFs, makes them attractive candidates 
for the use in luminescent sensors or fluorescent probes. [233, 234] 
Trivalent lanthanide ions have attractive features such as sharp 
characteristic emissions and long excited state lifetimes, allowing for 
lower costs but still maintaining high signal output and a simple 
detection mechanism.[235-240]  
 Thus far, the use of bio-MOFs as sensors has been rarely 
reported. Rosi et al. reported that the porous anionic 
[Zn8(Ade)4(bpdc)6∙O]∙2Me2NH2 in which the cations residing within 
the pores could be exchanged with lanthanide cations such as TbIII, 
SmIII and EuIII (Figure 8). [241] They further demonstrated that 
[Zn8(Ade)4(bpdc)6∙O]∙2Me2NH2 sensitizes near-infrared (NIR) 
emitting lanthanide cations in water. [241] Luminescence even in 
water is necessary for the use of NIR-emitting lanthanides in 
biological environments, eventually leading to the possibility of their 
potential applicability as intracellular O2 sensors. [241] For example, 
a sample of YbIII loaded bio-MOF-1 was dried, and observed a 40% 
decrease in YbIII luminescence within the first 5 minutes of 
introducing the sample to O2. [241] Upon purging the sample with 
N2, the signal intensity was restored, even after several cycles of 
exposure to O2 and N2. [241] 
In addition, Yan and Shen reported that the encapsulation of EuIII-
β-diketonate complexes within the same anionic Ade based bio-
MOF-1, it can applied in environmental and industrial sectors 
monitoring through sensing of volatile organic molecules, especially 
volatile amines. [237] The authors reported color switching due to 
the quenching of luminescence emission and lifetimes following 
exposure to acidic vapors (host luminescence still exists). [237] For 
environments with alkaline volatile organic molecules (e.g. HNEt2 - 
diethanolamine) the loaded bio-MOF-1 (EuIII0.005-TTA@bio-MOF-1) 
showed an enhanced red fluorescence emission whereas the 
material displayed a light purple fluorescence emission in the 
presence of acidic vapor (e.g. formic acid). [237] 
 9. Biological Applications  
Several methodologies have been reported to miniaturize MOFs 
into the nanoscale regime which is vital for their use in biology. 
Porous nanoscale MOFs have excellent properties such as drug 
storage-release capabilities, and the possibility of biocompatibility, 
making them appealing candidates for biomedical utility. [7, 120, 
242, 244] Thus far, the biomedical applications of bio-MOFs have not 
been fully explored due to a lack of reported materials that are stable 
in both aqueous and buffer conditions. For example, Rosi et  

Figure 9: Loaded Procainamide via cation exchange, followed by release. The 
release profile was determined through HPLC by placing a sample of the 
procainamide-exchanged material in 0.1 M, pH 7.4, PBS buffer (blue). Steady 
release of procainamide was observed over 72 hrs. To verify that the 
procainamide release was mediated by the buffer, a control experiment in 
nanopure water was performed, and verified that the release is indeed 
mediated by the buffer. (© 2009 American Chemical Society, reprinted with 
permission). [52] 
al. reported the construction of anionic 
[Zn8(Ade)4(bpdc)6O]∙2Me2NH2∙8DMF∙11H2O, which is stable for up to 
several weeks in both water and biological buffers. [52] The cationic 
drug molecule, Procainamide, was loaded via cation exchange into 
the pores of the material along with DMA cations that were originally 
found within the pores (Figure 9). [52] The drug release was 
monitored in a PBS buffer, and found that the cations in the buffer 
exchanged with those in the drug, likely aiding in the drug release 
process. [52] 
10. Conclusion and Future Outlook 
Bio-ligands are an attractive family of ligands that can be 
incorporated into MOF structures, with beneficial features such as 
multiple coordination sites, preinstalled chirality, 
hydrophobic/hydrophilic tendencies, specific recognition/self-
assembly capabilities, and they provide ideal characteristics for 
applications such as CO2 storage, catalysis and separation, sensing as 
well as drug-delivery. Bio-ligands are commercially available in high 
purities, or can be easily constructed through known literature 
procedures providing a nearly infinite variety of ligands, and allow 
researchers the ability to use different ligands than those typically 
explored.  
While they can have many different functionalities, their ability 
to bind through multiple coordination sites can afford the formation 
of bio-MOFs that span over several applications. Additional features 
of bio-MOFs constructed from bio-ligands is the ability to form 
flexible or robust frameworks, where both families are important 
and allow researchers to better understand the folding or movement 
of proteins or create robust materials for gas and storage 
applications. Concepts such as MTV-bio-MOFs, Ade-Thy replication, 
and the construction of isoreticular series have been proven and 
  
 
show impressive results. Furthermore, promising candidates such as 
[Ni2(L-Asp)2(bipy)]·guest, the Co-L-GlyGlu bio-MOF family, CD-MOF-1 
and -2, as well as [NH2(CH3)2][Zn3(4-Pca)3(Ade)]·10DMF·8H2O have 
been demonstrated for applications such as heterogeneous 
asymmetric catalysis, enantioselective adsorption/desorption, 
separation of xylene isomers and other light hydrocarbons. The 
[Zn8(Ade)4(bpdc)6O]∙2Me2NH2∙8DMF∙11H2O MOF was shown to take 
up and release the drug Procainamide, for drug delivery applications.  
 Through future research and construction of bio-MOFs, the 
properties, practical applications, structure and scope of this field 
will certainly grow. While there are very few bio-MOFs reported for 
applications such as catalysis, the discovery of new and novel bio-
MOFs could further expand the scope in all areas and answer 
questions such as improving hydrolytic stability of bio-MOFs for their 
use in biology. Exploring individual biological ligands, such as 
peptides, can give us more insight into the flexibility and collapse of 
pores, and if this can be beneficial for other applications such as gas 
storage and catalysis.[243] Furthermore, is it possible to stabilize 
these flexible bio-MOFs upon loading with specific molecules? By 
altering the structure, either through pre- or post-synthetic 
modification can we change the structure as a whole? For example, 
if CD is functionalized with functional groups to form an extended 
structure, do we still form CD cubes and are these going to be 
selective to CO2? While the formation of bio-MOFs, and exploration 
of their applications, is an ever growing field, many questions still 
need to be addressed that broach both the interests of bio-MOFs and 
MOFs, allowing us to further our understanding on the field as a 
whole.   
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Abbreviations (order as they presented in the 
review)  
MOFs: metal organic frameworks 
Bio-MOF: biologically derived MOFs 
Bio-ligands: biologically derived ligands 
MTV-MOF: Multivariate MOF 
IRMOF: Isoreticular MOF 
GFP: Green flurouescent protein  
HTCPB: tetradentate carboxylic acid 
BET: Brunauer–Emmett–Teller 
SCSC: single crystal to single crystal 
I: intensity 
CPO: coordination polymer 
LEDs: light-emitting diodes 
DMF: N,N′-dimethyl formamide 
DEF: N,N′-diethyl formamide 
FITC: Fluorescein isothiocyanate 
NMOFs: Nanoscale MOFs  
BTAsp: Benzene-1,3,5-tris aspartic acid 
Gly: Glycine 
Phe: Phenylalanine 
Gln: glutamine 
Asp: Aspartic acid 
SOD: Sodalite 
Met: methionine 
Glu: Glutamic acid 
His: Histidine 
Cys: Cysteine 
Tyr: Tyrosine 
Bipy: 4,4ʹ-bipyridyl 
Py3T: tris(4-pyridyl)-35bpp: 3,5-bis(4-pyridyl)pyridine 
IDS: meso-iminodisuccinic acid 
Im: imidazole 
Trp: Tryptophan 
bpe: bis(4-pyridyl)ethylene 
ser: serine 
val: valine 
BDC: benzene dicarboxylic acid 
GlyGly: Glycyl-Glycine 
GlyGlu: Glycyl-Glutamic acid 
GlyThr: Glycyl-Threonine 
AlaThr: Alanyl-Threonine 
GlyAla: Glycyl-Alanine 
GlyAsp: Glycyl-Aspartate 
GlySer: Glycyl-Serine 
MTV: multivariate  
Car or AlaHis: Carnosine or Alanyl-Histidine 
GlyHis: Glycyl-Histidine 
GlyPhe: Glycyl-Phenalanine 
GlyGlyGly: Glycyl-Glycyl-Glycine 
GlyProPro: Glycyl-Prolinyl-Proline 
BPDC: 4,4'-biphenyldicarboxylic acid 
GlyHisLys: Glycyl-Histidyl-Lysine 
GlyHisGly: Glycyl-Histidyl-Glysine 
NH2-Glu-pCO2Phe-pCO2Phe-Ala;Gly-OH: penta-peptide composed of 
the sequence of glutamic acid-phenylamine-phenylamine-alanine-
glycine 
Ade: adenine 
Thy: thymine 
TATB: 4,4ʹ,4″-s-Triazine-2,4,6-triyl-tribenzoic acid 
BTeC: 1,2,4,5-benzene tetracarboxylic acid 
Gua: guanine 
MOP: metal organic polyhedron 
TMOP: thymine based MOP 
MDPI: 5-((5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-
yl)methyl)isophthalate 
DMA: dimethyl acetimide 
XRD: X-ray diffraction 
α-CD: alpha-Cyclodextrin  
β-CD: beta-Cyclodextrin  
γ-CD: gamma-Cyclodextrin  
TCPB: 1,2,4,5-Tetrakis(4-carboxyphenyl)benzene 
CDMOF: Cyclodextrin based MOF 
α-1,4-D-Glup: α-1,4-linked D-glucopyranosyl 
SBUs: secondary building units 
ZABUs: zinc-adeninate octahedral building units 
NDC: 2,6-napthalene dicarboxylic acid  
ABDC: azo-benzene-4,4ʹ-dicarboxylic acid 
TPDC: terphenyldicarboxylic acid 
NH2-TPDC: 2ʹ-amino-1,1ʹ:4,1″-terphenyl-4,4″-dicarboxylate 
BTC: 1,3,5-benzene tricarboxylic acid 
PfH+: proflavine hemisulfate ion 
MB+: methylene blue ion
  
 
 
Azobipy: 4,4ʹ-azobipyrine 
Azinebipy: 4,4ʹ-azinebipyridine 
Bpeb: 1,4-bis(4-pyridylethenyl)-benzene 
Azpy: 4,4ʹ-azopyridine 
3rbp: 1,4-bis(4-pyridyl)benzene 
TMA+: tetramethyl-ammonium cations 
TEA+: tetraethyl-ammonium cations 
TBA+: tetrabutyl-ammonium cations 
pzdc: pyrazole dicarboxylic acid 
9Hade: adenine with protonated N9  
7Hade: adenine with protonated N7 
TiF6: titanium hexafluoride 
IAST: ideal adsorbed solution theory calculations 
GND+: guanidium cations 
AmGND+: aminoguanidinium cations 
DiAmGND+: diaminoguanidinium cations 
DMA+: dimethyl ammonium cations 
TIF: Tetrahedral imidazolate frameworks 
int: isonicotinic acid 
CA-CDMOF-2: Carbonic acid cyclodextrin based MOF 
e.e.: enantioselectivity 
HPLC: high performance liquid chromatography 
BTEX: acronym that stands for benzene, toluene, ethylbenzene, and 
xylenes 
4-Pca: 4-pyrazolecarboxylic acid  
HNEt2: diethynaloamine 
TTA: 2-thenoyltrifluoroacetonate 
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Table 1: Coordination binding modes of amino acids in MOFs. 
 
 
  
 
 
 
 
Table 2: Coordination binding modes of peptides in MOFs. 
 
 
 

                          
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Coordination binding modes of nucleobases in MOFs. 
 

  
  
Table 4: Coordination binding modes of saccharides in MOFs. 
 
 
